Professor Ian Ford

  • Professor of Biostatistics (Robertson Centre for Biostatistics)
  • Associate (School of Medicine, Dentistry and Nursing)

telephone: 01413304048
email: Ian.Ford@glasgow.ac.uk

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • ATTEST 2: Alteplase-Tenecteplase Thrombolysis Efficacy in Stroke Thrombolysis
    The Stroke Association
    2016 - 2021
     
  • Intravenous iron treatment in patients with heart failure and iron deficiency: a multicentre UK study (IRONMAN)
    British Heart Foundation
    2016 - 2020
     
  • Improving assessment, prediction and understanding of the short, medium and longer term neuropsychological consequences of stroke
    Stroke Association
    2016 - 2019
     
  • Reversal of T2DM to normal glucose tolerance using non-surgical weight management with low-energy-liquid-diet and long-term maintenance, within routine NHS care.
    Diabetes UK
    2016 - 2016
     
  • CLARIFY
    servier laboratories
    2015 - 2016
     
  • MISTIE III
    National Institute of Health
    2015 - 2016
     
  • Gene Therapy For Vein Graft Failure
    Medical Research Council
    2015 - 2019
     
  • Vitamin K therapy to improve vascular health in patients with Chronic Kidney Disease - a randomised controlled trial
    British Heart Foundation
    2015 - 2018
     
  • Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) trial: A randomised controlled trial of mechanical thrombectomy in acute ischaemic stroke
    National Institute for Health Research
    2015 - 2019
     
  • Programme of qualitative and quantitative systematic reviews of randomised controlled trials of homeopathy
    British Homeopathic Association
    2015 - 2017
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2015 - 2016
     
  • A randomised parallel group double blind placebo-controlled trial of low dose adjunctive alteplase during primary PCI (T-TIME)
    National Institute for Health Research
    2014 - 2017
     
  • Serum Chloride - epidemiology and genetic dissection of a novel marker of cardiovascular risk
    British Heart Foundation
    2014 - 2017
     
  • SurgiCal Obesity Treatment Study (SCOTS)
    National Institute for Health Research
    2014 - 2026
     
  • The APIPPRA Study: Arthritis Prevention In the Pre-clinical Phase of RA with Abatacept
    National Institute for Health Research
    2014 - 2016
     
  • MISTIE III
    National Institute of Health
    2014 - 2015
     
  • Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR 3)
    National Institute of Health
    2014 - 2015
     
  • Treatment in the Morning Versus Evening Study (TIME)
    British Heart Foundation
    2014 - 2019
     
  • Explaining excess winter mortality from CHD: analysis of UK based prospective studies
    British Heart Foundation
    2014 - 2016
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2014 - 2015
     
  • Stratified Medicine Phase One: Clinical Hubs - March 2011
    Cancer Research UK
    2014 - 2014
     
  • PrEscription of intraDialytic exercise to improve quAlity of Life (PEDAL Trial)
    National Institute for Health Research
    2014 - 2017
     
  • Reversal of T2DM to normal glucose tolerance using non-surgical weight management with low-energy-liquid-diet and long-term maintenance, within routine NHS care.
    Diabetes UK
    2014 - 2018
     
  • SIGNIFY - CL3-16257-083
    Institute Of Research International Servier
    2013 - 2014
     
  • A Programme for Prevention & Treatment of Resistant Hypertension with Algorthm Based Therapy - Pathway.
    British Heart Foundation
    2013 - 2015
     
  • MISTIE III
    National Institute of Health
    2013 - 2014
     
  • Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL HEART).
    Health Technology Assessment
    2013 - 2019
     
  • Palliative Care Needs in Patients with Heart Failure
    British Heart Foundation
    2013 - 2016
     
  • Gene Therapy For Vein Graft Failure
    Medical Research Council
    2013 - 2018
     
  • Stratified Medicine Clinical Hub
    Cancer Research UK
    2013 - 2013
     
  • Stratified Medicine Phase One: Clinical Hubs - March 2011
    Cancer Research UK
    2013 - 2013
     
  • Penumbra and Recanalisation Acute CT in Ischaemic Stroke Evaluation (PRACTISE)
    National Institute for Health Research
    2013 - 2016
     
  • Data Management & Statistical Analysis for The Proactive IV Iron Therapy in DiALysis Patients (PIVOTAL)Study.
    Kidney Research UK
    2013 - 2018
     
  • Contribution to the Development of the Biorepository Laboratory Information Management System (LIMS) under the Glasgow Biomedicine Research Collaboration
    Scottish Executive Health Department
    2013 - 2014
     
  • A Parallel group Randomised Open Blinded Evaluation of Acceptance and Commitment Therapy for Depression After Psychosis: A Pilot Trial (ADAPT)
    Scottish Executive Health Department
    2013 - 2015
     
  • The Scottish eHealth Informatics Research Centre (E-HIRCs)
    Medical Research Council
    2013 - 2018
     
  • Vertebral artery Ischamemia Stenting Trial (VIST)
    National Institute for Health Research
    2013 - 2018
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2013 - 2014
     
  • Stratified Medicine Phase One: Clinical Hubs - March 2011
    Cancer Research UK
    2012 - 2012
     
  • Learning disabilities - The Scottish Learning Disabilities Observatory
    Scottish Government - Health and Social Care Integration Dir
    2012 - 2018
     
  • Research on the British Society for Rheumatology Biologics Register: Ankylosing Spondylitis
    British Society for Rheumatology
    2012 - 2017
     
  • Programme of qualitative and quantitative systematic reviews of randomised controlled trials of homeopathy
    British Homeopathic Association
    2012 - 2014
     
  • PRIMAD AS
    National Institute for Health Research
    2012 - 2015
     
  • PISTE (Pragmatic Ischaemic Stroke Thrombectomy Evaluation)
    The Stroke Association
    2012 - 2014
     
  • Prosper Analysis
    NHS Greater Glasgow and Clyde
    2012 - 2014
     
  • SurgiCal Obesity Treatment Study (SCOTS)
    National Institute for Health Research
    2012 - 2026
     
  • TRUST: Multi-modal effects of thyroid hormone replacement for untreated older adults with subclinical hypothyroidism; a randomised placebo-controlled trial
    European Commission
    2011 - 2016
     
  • Fractional Flow Reserve versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes: a Developmental Clinical Study
    British Heart Foundation
    2011 - 2014
     
  • Gene Therapy for Vein Graft Failure
    MRC
    2011 - 2016
     
  • Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR 3)
    National Institute of Health
    2011 - 2013
     
  • Stratified Medicine Phase One: Clinical Hubs - March 2011
    Cancer Research UK
    2011 - 2013
     
  • EHR4CR
    European Commission
    2011 - 2015
     
  • Provision of mentoring for TCTU Staff
    Scottish Executive Health Department
    2011 - 2012
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2011 - 2012
     
  • Acquired Heart Valve Disease in Scotland: An epidemiological study
    Scottish Executive Health Department
    2011 - 2012
     
  • Biological, demographic, cognitive and social determinants of health outcomes in older people: results from within-study and extended follow-up of the PROSPER trial.
    Scottish Executive Health Department
    2010 - 2013
     
  • Scottish Early Rheumatoid Arthritis (SERA) bio-bank from an inception cohort of patients with newly diagnosed rheumatoid arthritis
    Scottish Executive Health Department
    2010 - 2013
     
  • Psychological Interventions and Investigations in Personality Disorders
    Scottish Mental Health Research Network
    2010 - 2012
     
  • NT-proBNP as a predictor of vascular events in WOSCOPS: using modern epidemiological techniques to test clinical utility of a biomarker
    British Heart Foundation
    2010 - 2012
     
  • Evaluation of electrocardiographic monitoring strategy to identify atrial fibrillation in patients with recent acute stroke
    Scottish Executive Health Department
    2010 - 2011
     
  • Statistical analysis of the Nat. Heart failure Audit.
    NHS Greater Glasgow and Clyde
    2009 - 2010
     
  • Promoting physical independence by involving users in rehabilitation through dynamic visualisations of movement data
    MRC
    2009 - 2013
     
  • MaXED
    NHS Fife
    2009 - 2016
     
  • Assessing vascular disease, and its association with insulin resistance and adiposity in South Asians
    Chest, Heart & Stroke, Scotland
    2009 - 2011
     
  • From absolute risk to absolute benefit in the prevention of cardiovascular disease: a cardiovascular policy model for Scotland (ASSIGN Plus)
    Scottish Executive Health Department
    2009 - 2011
     
  • Scottish Health Informatics Programme ( SHIP )
    Wellcome Trust
    2009 - 2013
     
  • Can high-dose vitamin D supplementation reduce blood pressure and markers of cardiovascular risk in older people with isolated systolic hypertension?
    Scottish Executive Health Department
    2009 - 2012
     
  • Investigation of the beneficial and adverse effects of induction of labour
    Scottish Executive Health Department
    2009 - 2009
     
  • Long-term follow-up of older people in the PROSPER study cohort: pilot study to determine feasibility of determining cognitive function and disability in survivors.
    Scottish Executive Health Department
    2009 - 2009
     
  • Central adjudication of modified Rankin scale disability assessments in acute stroke trials
    Scottish Executive Health Department
    2009 - 2010
     
  • PHASE: A Pharmacogenomic Study of Statins in the Elderly at Risk for Cardiovascular Disease
    European Commission
    2009 - 2011
     
  • Yakult Study
    NHS Greater Glasgow and Clyde
    2008 - 2010
     
  • The effect of spironolactone on exercise capacity in functionally impaired older people without heart failure: a double blind placebo controlled trial
    Scottish Executive Health Department
    2008 - 2011
     
  • Effect of metformin on progression of carotid atherosclerosis in non-diabetic patients with CHD optimally treated with conventional risk reducing agents
    Scottish Executive Health Department
    2008 - 2012
     
  • A Programme for Prevention & Treatment of Resistant Hypertension with Algorthm Based Therapy - Pathway.
    British Heart Foundation
    2008 - 2013
     
  • National e-Science Centre Research Platform (NRP)
    EPSRC
    2008 - 2013
     
  • 5 Year Outcome of Early Rheumatoid Arthritis (RA) Therpay in the West of Scotland: Predictive factors and practical resource planning
    Scottish Executive Health Department
    2008 - 2008
     
  • Attention bias as an etiologic factor in primary and secondary insomnia
    National Institute of Health (USA)
    2008 - 2013
     
  • Additional Work on the pSoBid Study
    Glasgow Centre for Population Health
    2008 - 2008
     
  • Testing novel metabolic and inflammatory predictors of CVD [cardiovascular disease]and stroke events, and all cause mortality in WOSCOPS [West of Scotland Coronary Prevention Study ]...
    Chest, Heart & Stroke, Scotland
    2008 - 2009
     
  • Periscope MILA [Multi-institution approach to linkage and anonymisation] Demonstrator Project
    Scottish Executive Health Department
    2008 - 2009
     
  • Quantifying myocardial microvascular obstruction in patients with STEMI (ST elevation myocardial infarction)
    Scottish Executive Health Department
    2008 - 2010
     
  • Placebo Adherence Study
    National Institute of Health (USA)
    2007 - 2010
     
  • Proinflammatory cytokines as biomarkers for risk of stroke
    Scottish Executive Health Department
    2007 - 2007
     
  • Inflammation and haemostatic dysfunction - novel risk factors for cognitive decline in older patients with vascular risk factors or disease
    Scottish Executive Health Department
    2006 - 2008
     
  • Glasgow Statistical Reviews for PLoS Medicine
    Public Library of Science
    2006 - 2008
     
  • Cancer Care Study
    University of Stirling
    2006 - 2007
     
  • Scottish Collaboration of Trialists (SCOT) - Supporting excellence & building capacity in multicentre, clinical network-based randomised...
    Scottish Higher Education Funding Council
    2005 - 2009
     
  • Virtual organizations for trials and epidemiological studies (VOTES)
    MRC
    2005 - 2009
     
  • Centralised Eudravigilance System for Glasgow
    Scottish Executive Health Department (Ch Scientist Off)
    2005 - 2006
     
  • The impact of deprivation and ethnicity on prevalence of diabetes and its complications - the Glasgow Diabetes project
    Diabetes UK
    2005 - 2006
     
  • FSGS Study
    North Glasgow University Hospitals NHS Trust
    2005 - 2005
     
  • Risk factors for the development of incident thrombotic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
    Chest, Heart & Stroke, Scotland
    2005 - 2006
     
  • Co-ordinating Centre for the UK Stroke Research Network
    Department of Health
    2005 - 2010
     
  • Generation Scotland
    Scottish Executive Health Department
    2005 - 2011
     
  • Co-ordinating Centre for the UK Stroke Research Network
    Department of Health
    2005 - 2015
     
  • Long-term follow-up of WOSCOPS subjects: assessment of long-term benefits of treatment with pravastatin and relationships of baseline hsCRP and WCC with fatal and non-fatal cancers
    Scottish Executive Health Department
    2005 - 2006
     
  • Insulin sensitization as a novel mechanism to lessen ischaemic burden in non-diabetic patients with chronic stable angina - a pilot study
    British Heart Foundation
    2005 - 2007
     
  • Factors determining physical and mental well being in affluent and deprived communities in Glasgow
    Glasgow Centre for Population Health
    2005 - 2007
     
  • Validation of myocardial perfusion magnetic resonance imaging using combined assessment of coronary and fractional flow reserve
    British Heart Foundation
    2004 - 2006
     
  • Relevance of inflammation sensitive pathways to stroke, coronary events and cognitive decline in the elderly in PROSPER
    Chest, Heart & Stroke, Scotland
    2004 - 2005
     
  • Predictors and pattern of transition to type 2 diabetes - novel insights from the West of Scotland coronary prevention study
    Diabetes UK
    2004 - 2005
     
  • Can guiding medical treatment by measurement of blood N-terminal pro BNP concentration improve outcome in chronic heart failure?
    British Heart Foundation
    2004 - 2006
     
  • Pharmacogenics of the statin response (PROSPER STUDY)
    National Institutes of Health
    2003 - 2008
     
  • A role for novel candidate pathways in cerebrovascular disease and cognitive decline in the elderly?
    The Stroke Association
    2003 - 2005
     
  • Does the aldosterone:Renin ratio predict the efficacy of spironolactone over bendrofluazide in hypertension? A pragmatic randomised .......
    Scottish Executive Health Department
    2002 - 2006
     
  • Determinants of five year health and well-being status following coronary artery bypass grafting - study with Dr Grace Lindsay
    Scottish Executive Health Department
    2002 - 2005
     
  • Scottish Schizophrenia Outcome Study
    NHS Quality Improvement Scotland
    2002 - 2005
     

Publications

List by: Type | Date

Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1980
Number of items: 388.

2016

Carrick, D. et al. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1(6), e85768. (doi:10.1172/jci.insight.85768)

Lee, M. M.Y. et al. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS). Open Heart, 3(1), e000371. (doi:10.1136/openhrt-2015-000371) (PMID:27110377) (PMCID:PMC4838768)

Carrick, D. et al. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37(13), pp. 1044-1059. (doi:10.1093/eurheartj/ehv372) (PMID:26261290)

Gonzalez-Valcarcel, J. et al. (2016) Paracetamol, ibuprofen, and recurrent major cardiovascular and major bleeding events in 19 120 patients with recent ischemic stroke. Stroke, 47(4), pp. 1045-1052. (doi:10.1161/strokeaha.115.012091) (PMID:26979864)

Trompet, S. et al. (2016) Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies. European Journal of Clinical Pharmacology, 72(4), pp. 431-437. (doi:10.1007/s00228-015-1994-9) (PMID:26686871)

Elliott, H. L., Lloyd, S. M., Ford, I., and Meredith, P. (2016) Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system. Blood Pressure, 25(2), pp. 67-73. (doi:10.3109/08037051.2015.1127526) (PMID:26796694)

Meredith, P. A., Lloyd, S. M., Ford, I., and Elliott, H. L. (2016) Importance of sustained and “tight” blood pressure control in patients with high cardiovascular risk. Blood Pressure, 25(2), pp. 74-82. (doi:10.3109/08037051.2015.1127528)

Clarke, A. T., Johnson, P. C.D., Hall, G. C., Ford, I., and Mills, P. (2016) High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort. PLoS ONE, 11(3), e0151587. (doi:10.1371/journal.pone.0151587) (PMID:26983033)

Pisano, U., Deosaran, J., Leslie, S. J., Rushworth, G. F., Stewart, D., Ford, I., and Watson, A. J. M. (2016) Nicorandil, gastrointestinal adverse drug reactions and ulcerations: a systematic review. Advances in Therapy, 33(3), pp. 320-344. (doi:10.1007/s12325-016-0294-9) (PMID:26861848)

Kilpeläinen, T. O. et al. (2016) Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nature Communications, 7, 10494. (doi:10.1038/ncomms10494) (PMID:26833098) (PMCID:PMC4740377)

Brown, M. J. et al. (2016) Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes and Endocrinology, 4(2), pp. 136-147. (doi:10.1016/s2213-8587(15)00377-0) (PMID:26489809) (PMCID:PMC4728199)

Carrick, D. et al. (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-elevation myocardial infarction: pathophysiologic insights and clinical implications. Journal of the American Heart Association, 5, e002834. (PMID:26908408)

Ibrahim-Verbaas, C. A. et al. (2016) GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Molecular Psychiatry, 21(2), pp. 189-197. (doi:10.1038/mp.2015.37) (PMID:25869804) (PMCID:PMC4722802)

Gorcsan, J. et al. (2016) Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial. European Heart Journal, 37(1), pp. 49-59. (doi:10.1093/eurheartj/ehv418) (PMID:26321238)

Carberry, J. et al. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, (Accepted for Publication)

Carrick, D. et al. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9(1), e004148. (doi:10.1161/CIRCIMAGING.115.004148)

Dehghan, A. et al. (2016) Genome wide association study for incident myocardial infarction and coronary heart disease in prospective cohort studies: the CHARGE consortium. PLoS ONE, 11(3), e0144997. (doi:10.1371/journal.pone.0144997) (PMID:26950853) (PMCID:PMC4780701)

Ford, I., Murray, H., Mccowan, C., and Packard, C. J. (2016) Long term safety and efficacy of lowering LDL cholesterol with statin therapy: 20-year follow-up of West of Scotland coronary prevention study. Circulation, (doi:10.1161/CIRCULATIONAHA.115.019014) (Early Online Publication)

Lawson, K., Briggs, A., Lewsey, J., Ford, I., Watt, G., Tunstall-Pedoe, H., Woodward, M., Ritchie, L., Kent, S., and Neilson, M. (2016) A cardiovascular disease policy model: part 2 – preparing for economic evaluation and to assess health inequalities. Open Heart, (Accepted for Publication)

Leslie, W. S. et al. (2016) The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Family Practice, 17(1), (doi:10.1186/s12875-016-0406-2) (PMID:26879684) (PMCID:PMC4754868)

Tendera, M., Chassany, O., Ferrari, R., Ford, I., Steg, P. G., Tardif, J.-C., and Fox, K. (2016) Quality of life with ivabradine in patients with angina pectoris. Circulation: Cardiovascular Quality and Outcomes, (doi:10.1161/circoutcomes.115.002091) (PMID:26696613) (Early Online Publication)

2015

Böhm, M., Robertson, M., Ford, I., Borer, J. S., Komajda, M., Kindermann, I., Maack, C., Lainscak, M., Swedberg, K., and Tavazzi, L. (2015) Influence of cardiovascular and noncardiovascular co-morbidities on outcomes and treatment effect of heart rate reduction With Ivabradine in stable heart failure (from the SHIFT Trial). American Journal of Cardiology, 116(12), pp. 1890-1897. (doi:10.1016/j.amjcard.2015.09.029) (PMID:26508709)

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., and Ferrari, R. (2015) Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. European Heart Journal, 36(46), pp. 3291-3296. (doi:10.1093/eurheartj/ehv451) (PMID:26385957)

Komajda, M., Tavazzi, L., Francq, B., Böhm, M., Borer, J. S., Ford, I., and Swedberg, K. (2015) Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial. European Journal of Heart Failure, 17(12), pp. 1294-1301. (doi:10.1002/ejhf.347) (PMID:26377342)

Packard, C., and Ford, I. (2015) Long-term follow-up of lipid-lowering trials. Current Opinion in Lipidology, 26(6), pp. 572-579. (doi:10.1097/mol.0000000000000230)

Williams, B. et al. (2015) Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet, 386(10008), pp. 2059-2068. (doi:10.1016/S0140-6736(15)00257-3) (PMID:26414968) (PMCID:PMC4655321)

Hofer, E. et al. (2015) White matter lesion progression: genome-wide search for genetic influences. Stroke, 46(11), pp. 3048-3057. (doi:10.1161/STROKEAHA.115.009252) (PMID:26451028)

Rogers, J. K., Kielhorn, A., Borer, J. S., Ford, I., and Pocock, S. J. (2015) Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients. Current Medical Research and Opinion, 31(10), pp. 1903-1909. (doi:10.1185/03007995.2015.1080155) (PMID:26361063)

Hamill, V. et al. (2015) Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction. American Journal of Medicine, 128(10), 1102-1108.e6. (doi:10.1016/j.amjmed.2015.04.042) (PMID:26044936)

Nikpay, M. et al. (2015) A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease. Nature Genetics, 47(10), pp. 1121-1130. (doi:10.1038/ng.3396) (PMID:26343387)

Gumley, A. et al. (2015) A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for Depression After Psychosis: A Pilot Trial Protocol (ADAPT). Psychosis, pp. 1-13. (doi:10.1080/17522439.2015.1100669)

Morris, R. W. et al. (2015) Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium: Table 1. BMJ Open, 5(8), e008808. (doi:10.1136/bmjopen-2015-008808) (PMID:26264275) (PMCID:PMC4538266)

Steffel, J. et al. (2015) The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. European Heart Journal, 36(30), pp. 1983-1989. (doi:10.1093/eurheartj/ehv242) (PMID:26009595)

Joshi, P. K. et al. (2015) Directional dominance on stature and cognition in diverse human populations. Nature, 523(7561), pp. 459-462. (doi:10.1038/nature14618) (PMID:26131930)

Bocchi, E. A., Bohm, M., Borer, J.S., Ford, I., Komajda, M., Swedberg, K., and Tavazzi, L. (2015) Effect of combining ivabradine and β-blockers: focus on the use of carvedilol in the SHIFT population. Cardiology, 131(4), pp. 218-224. (doi:10.1159/000380812) (PMID:25968495)

Carrick, D. et al. (2015) Pathophysiology of LV remodeling in survivors of STEMI : inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging, 8(7), pp. 779-789. (doi:10.1016/j.jcmg.2015.03.007) (PMID:26093923) (PMCID:PMC4509710)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, 36(24), pp. 1536-1546. (doi:10.1093/eurheartj/ehv072) (PMID:25802390)

Böhm, M. et al. (2015) Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy. European Journal of Heart Failure, 17(5), pp. 518-526. (doi:10.1002/ejhf.258) (PMID:25801408)

Ford, I. (2015) Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet, 385(9976), pp. 1397-1405. (doi:10.1016/S0140-6736(14)61368-4)

Ford, I., Robertson, M., Komajda, M., Böhm, M., Borer, J. S., Tavazzi, L., and Swedberg, K. (2015) Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: the SHIFT risk model. International Journal of Cardiology, 184, pp. 163-169. (doi:10.1016/j.ijcard.2015.02.001) (PMID:25703424)

Huang, X., Cheripelli, B. K., Lloyd, S. M., Kalladka, D., Moreton, F. C., Siddiqui, A., Ford, I., and Muir, K. W. (2015) Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST): phase 2 randomised clinical trial. Lancet Neurology, 14(4), pp. 368-376. (doi:10.1016/S1474-4422(15)70017-7) (PMID:25726502)

Zimmermann, E. et al. (2015) Is the adiposity-associatedFTOgene variant related to all-cause mortality independent of adiposity? Meta-analysis of data from 169,551 Caucasian adults. Obesity Reviews, 16(4), pp. 327-340. (doi:10.1111/obr.12263)

Borer, J. S., Böhm, M., Ford, I., Komajda, M., Swedberg, K., and Tavazzi, L. (2015) Effect of ivabradine on early readmissions after hospitalization for worsening heart failure. JACC: Heart Failure, 3(3), pp. 268-269. (doi:10.1016/j.jchf.2014.12.004) (PMID:25742766)

Campbell, R. T. et al. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2(1), pp. 25-36. (doi:10.1002/ehf2.12027)

Ponikowski, P. et al. (2015) The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. European Journal of Heart Failure, 17(3), pp. 329-339. (doi:10.1002/ejhf.229) (PMID:25683972) (PMCID:PMC4413361)

Wijsman, L. W., de Craen, A. J.M., Muller, M., Sabayan, B., Stott, D., Ford, I., Trompet, S., Jukema, J. W., Westendorp, R. G.J., and Mooijaart, S. P. (2015) Blood pressure lowering medication, visit-to-visit blood pressure variability, and cognitive function in old age. American Journal of Hypertension, 29(3), pp. 311-318. (doi:10.1093/ajh/hpv101) (PMID:26156873)

Shungin, D. et al. (2015) New genetic loci link adipose and insulin biology to body fat distribution. Nature, 518(7538), pp. 187-196. (doi:10.1038/nature14132) (PMID:25673412) (PMCID:PMC4338562)

Davies, G. et al. (2015) Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949). Molecular Psychiatry, 20(2), pp. 183-192. (doi:10.1038/mp.2014.188) (PMID:25644384) (PMCID:PMC4356746)

Pers, T. H. et al. (2015) Biological interpretation of genome-wide association studies using predicted gene functions. Nature Communications, 6, p. 5890. (doi:10.1038/ncomms6890) (PMCID:PMC4420238)

Layland, J. et al. (2015) Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. European Heart Journal, 36(2), pp. 100-111. (doi:10.1093/eurheartj/ehu338) (PMID:25179764) (PMCID:PMC4291317)

Swerdlow, D. I. et al. (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet, 385(9965), pp. 351-361. (doi:10.1016/S0140-6736(14)61183-1) (PMID:25262344) (PMCID:PMC4322187)

Bis, J. C. et al. (2015) Drug-gene interactions of antihypertensive medications and risk of incident cardiovascular disease: a pharmacogenomics study from the CHARGE consortium. PLoS ONE, 10(10), e0140496. (doi:10.1371/journal.pone.0140496) (PMID:26516778) (PMCID:PMC4627813)

Brown, M. J. et al. (2015) Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension. BMJ Open, 5(8), e008086. (doi:10.1136/bmjopen-2015-008086) (PMID:26253567) (PMCID:PMC4539390)

Carrick, D. et al. (2015) Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), Q:52. (doi:10.1186/1532-429X-17-S1-Q52) (PMCID:PMC4328295)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O54. (doi:10.1186/1532-429X-17-S1-O54) (PMCID:PMC4328590)

Carrick, D. et al. (2015) Prognostic significance of quantitative measures of myocardial infarct pathology using native T1 mapping, in survivors of ST-elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O53. (doi:10.1186/1532-429X-17-S1-O53) (PMCID:PMC4328908)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by non-contrast T1 mapping cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O26. (doi:10.1186/1532-429X-17-S1-O26) (PMCID:PMC4328668)

Chaker, L. et al. (2015) Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. Journal of Clinical Endocrinology and Metabolism, 100(6), pp. 2181-2191. (doi:10.1210/jc.2015-1438) (PMID:25856213)

Cook, J. A. et al. (2015) Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers. Trials, 16(1), 12. (doi:10.1186/s13063-014-0526-8) (PMID:25928502) (PMCID:PMC4302137)

Fauchier, L., Greenlaw, N., Ferrari, R., Ford, I., Fox, K. M., Tardif, J.-C., Tendera, M., and Steg, P. G. (2015) Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry. PLoS ONE, 10(4), e0125164. (doi:10.1371/journal.pone.0125164) (PMID:25915904) (PMCID:PMC4411156)

Galiè, N. et al. (2015) Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. New England Journal of Medicine, 373(9), pp. 834-844. (doi:10.1056/NEJMoa1413687) (PMID:26308684)

Locke, A. E. et al. (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), pp. 197-206. (doi:10.1038/nature14177) (PMID:25673413) (PMCID:PMC4382211)

Loeffen, R., Winckers, K., Ford, I., Jukema, J. W., Robertson, M., Stott, D. J., Spronk, H. M., ten Cate, H., and Lowe, G. (2015) Associations between thrombin generation and the risk of cardiovascular disease in elderly patients: results from the PROSPER study. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 70(8), pp. 982-988. (doi:10.1093/gerona/glu228) (PMID:25540034)

Logue, J. et al. (2015) SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in Scotland. BMJ Open, 5(5), e008106. (doi:10.1136/bmjopen-2015-008106) (PMID:26002692) (PMCID:PMC4442215)

MacDonald, T. M. et al. (2015) Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial: figure 1. BMJ Open, 5(8), e007645. (doi:10.1136/bmjopen-2015-007645) (PMID:26253566)

Mccowan, C., Thomson, E., Szmigielski, C. A., Kalra, D., Sullivan, F. M., Prokosch, H.-U., Dugas, M., and Ford, I. (2015) Using electronic health records to support clinical trials: a report on stakeholder engagement for EHR4CR. BioMed Research International, 2015, 707891. (doi:10.1155/2015/707891) (PMID:26539523) (PMCID:PMC4619877)

Poortvliet, R. K.E. et al. (2015) Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. American Journal of Hypertension, 28(4), pp. 469-479. (doi:10.1093/ajh/hpu181) (PMID:25298176)

Templin, C. et al. (2015) Clinical features and outcomes of takotsubo (stress) cardiomyopathy. New England Journal of Medicine, 373(10), pp. 929-938. (doi:10.1056/NEJMoa1406761) (PMID:26332547)

Williams, B. et al. (2015) Prevention And treatment of hypertension with algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension. BMJ Open, 5(8), e008951. (doi:10.1136/bmjopen-2015-008951) (PMID:26253568) (PMCID:PMC4538257)

2014

McCowan, C., and Ford, I. (2014) Clinical trials in crisis: four simple methodologic fixes commentary. Clinical Trials, 11(6), pp. 624-625. (doi:10.1177/1740774514553483)

Mccowan, C., and Ford, I. (2014) Commentary on Vickers. Clinical Trials, 11(6), pp. 624-625. (doi:10.1177/1740774514553483) (PMID:25389226)

Welsh, P. et al. (2014) Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia, 57(12), pp. 2513-2520. (doi:10.1007/s00125-014-3383-9)

Steg, P. G. et al. (2014) Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the international observational CLARIFY registry. JAMA Internal Medicine, 174(10), pp. 1651-1659. (doi:10.1001/jamainternmed.2014.3773) (PMID:25110899)

Tendera, M. et al. (2014) Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. International Journal of Cardiology, 176(1), pp. 119-124. (doi:10.1016/j.ijcard.2014.06.052) (PMID:25042656)

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., and Ferrari, R. (2014) Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure. New England Journal of Medicine, 371(12), pp. 1091-1099. (doi:10.1056/NEJMoa1406430) (PMID:25176136)

Anker, S.D. et al. (2014) The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. European Heart Journal, 35(30), pp. 2001-2009. (doi:10.1093/eurheartj/ehu205)

Wijsman, L. W. et al. (2014) N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Annals of Neurology, 76(2), pp. 213-222. (doi:10.1002/ana.24203)

Witham, M. D., Price, R. J.G., Struthers, A. D., Donnan, P. T., Messow, M., McConnachie, A., Ford, I., and McMurdo, M. E.T. (2014) Effect of vitamin D supplementation on orthostatic hypotension. Journal of Hypertension, 32(8), pp. 1693-1699. (doi:10.1097/HJH.0000000000000223) (PMID:24879494)

Akao, H. et al. (2014) ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment. Atherosclerosis, 235(1), pp. 176-181. (doi:10.1016/j.atherosclerosis.2014.04.030) (PMID:24854628)

Komajda, M., Böhm, M., Borer, J. S., Ford, I., Robertson, M., Manolis, A. J., Tavazzi, L., and Swedberg, K. (2014) Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT. European Journal of Heart Failure, 16(7), pp. 810-816. (doi:10.1002/ejhf.114)

Postmus, I. et al. (2014) In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. Atherosclerosis, 235(1), pp. 58-64. (doi:10.1016/j.atherosclerosis.2014.04.009)

Carrick, D. et al. (2014) A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). Journal of the American College of Cardiology, 63(20), pp. 2088-2098. (doi:10.1016/j.jacc.2014.02.530)

Cooke, J. A. et al. (2014) Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. Health Technology Assessment, 18(28), v-vi, 1. (doi:10.3310/hta18280)

Lubitz, S.A. et al. (2014) Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. Journal of the American College of Cardiology, 63(12), pp. 1200-1210. (doi:10.1016/j.jacc.2013.12.015)

Voors, A. A., van Veldhuisen, D. J., Robertson, M., Ford, I., Borer, J. S., Bohm, M., Komajda, M., Swedberg, K., and Tavazzi, L. (2014) The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT. European Journal of Heart Failure, 16(4), pp. 426-434. (doi:10.1002/ejhf.59)

Di Angelantonio, E. et al. (2014) Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA: Journal of the American Medical Association, 311(12), pp. 1225-1233. (doi:10.1001/jama.2014.1873) (PMID:24668104) (PMCID:PMC4386007)

Virgini, V.S. et al. (2014) Subclinical thyroid dysfunction and functional capacity among elderly. Thyroid, 24(2), pp. 208-214. (doi:10.1089/thy.2013.0071)

Borer, J.S., Böhm, M., Ford, I., Robertson, M., Komajda, M., Tavazzi, L., and Swedberg, K. (2014) Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT Study). American Journal of Cardiology, 113(3), pp. 497-503. (doi:10.1016/j.amjcard.2013.10.033)

Preiss, D., Lloyd, S. M., Ford, I., McMurray, J. J.V., Holman, R. R., Welsh, P., Fisher, M., Packard, C. J., and Sattar, N. (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes and Endocrinology, 2(2), pp. 116-124. (doi:10.1016/S2213-8587(13)70152-9) (PMID:24622715)

Drewes, Y.M. et al. (2014) Homocysteine levels and treatment effect in the prospective study of pravastatin in the elderly at risk. Journal of the American Geriatrics Society, 62(2), pp. 213-221. (doi:10.1111/jgs.12660)

Jennings, C., Flynn, R., Ford, I., Nuki, G., MacDonald, T., and Mackenzie, I. (2014) Up-titration of allopurinol in patients with gout. Scottish Medical Journal, 59(1), E24-E25. (doi:10.1177/0036933013518461)

Avery, C.L. et al. (2014) Drug–gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval. Pharmacogenomics Journal, 14(1), pp. 6-13. (doi:10.1038/tpj.2013.4)

Baumert, J. et al. (2014) No evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: results from meta-analyses of 80,607 subjects. PLoS ONE, 9(12), e111156. (doi:10.1371/journal.pone.0111156)

Bots, M.L., Ford, I., Lloyd, S.M., Laurent, S., Touboul, P.J., and Hennerici, M.G. (2014) Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial. Stroke, 45(8), pp. 2348-2353. (doi:10.1161/STROKEAHA.114.004775)

Deelen, J. et al. (2014) Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Human Molecular Genetics, 23(16), pp. 4420-4432. (doi:10.1093/hmg/ddu139)

Ferrari, R., Ford, I., Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H., Fox, K., Hu, D., Shalnova, S., and Steg, P. G. (2014) Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. European Journal of Preventive Cardiology, 22(8), pp. 1056-1065. (doi:10.1177/2047487314547652)

Holmes, M. V. et al. (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ, 349, g4164. (doi:10.1136/bmj.g4164)

Huang, J. et al. (2014) Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arteriosclerosis, Thrombosis and Vascular Biology, 34(5), pp. 1093-1101. (doi:10.1161/ATVBAHA.113.302088)

Kalra, P. R. et al. (2014) Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS ONE, 9(7), e102335. (doi:10.1371/journal.pone.0102335)

Lewsey, J.D. et al. (2014) A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation. Heart, 101(3), pp. 201-208. (doi:10.1136/heartjnl-2014-305637)

Lundby, A. et al. (2014) Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics. Nature Methods, 11(8), pp. 868-874. (doi:10.1038/NMETH.2997)

MacDonald, T. M. et al. (2014) Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open, 4(7), e005354. (doi:10.1136/bmjopen-2014-005354)

McConnachie, A., Walker, A., Robertson, M., Marchbank, L., Peacock, J., Packard, C.J., Cobbe, S.M., and Ford, I. (2014) Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. European Heart Journal, 35(5), pp. 290-298. (doi:10.1093/eurheartj/eht232)

Oei, L. et al. (2014) A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus. Journal of Medical Genetics, 51(2), pp. 122-131. (doi:10.1136/jmedgenet-2013-102064)

Postmus, I. et al. (2014) Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nature Communications, 5(5068), (doi:10.1038/ncomms6068)

Sinner, M. F. et al. (2014) Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation, 130(15), pp. 1225-1235. (doi:10.1161/CIRCULATIONAHA.114.009892)

Taylor, A. E. et al. (2014) Stratification by smoking status reveals an association of CHRNA5-A3-B4 genotype with body mass index in never smokers. PLoS Genetics, 10(12), e1004799. (doi:10.1371/journal.pgen.1004799)

Wood, A. R. et al. (2014) Defining the role of common variation in the genomic and biological architecture of adult human height. Nature Genetics, 46(11), pp. 1173-1186. (doi:10.1038/ng.3097)

2013

Tavazzi, L., Swedberg, K., Komajda, M., Böhm, M., Borer, J.S., Lainscak, M., Robertson, M., and Ford, I. (2013) Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. International Journal of Cardiology, 170(2), pp. 182-188. (doi:10.1016/j.ijcard.2013.10.068)

Cavanagh, J. et al. (2013) Socioeconomic status and the cerebellar grey matter volume. Data from a well-characterised population sample. Cerebellum, 12(6), pp. 882-891. (doi:10.1007/s12311-013-0497-4)

Parsa, A. et al. (2013) Common variants in mendelian kidney disease genes and their association with renal function. Journal of the American Society of Nephrology, 24(12), pp. 2105-2117. (doi:10.1681/ASN.2012100983)

Sabayan, B., van der Grond, J., Westendorp, R.G., Jukema, J.W., Ford, I., Buckley, B.M., Sattar, N., van Osch, M.J.P., van Buchem, M.A., and de Craen, A.J.M. (2013) Total cerebral blood flow and mortality in old age: a 12-year follow-up study. Neurology, 81(22), pp. 1922-1929. (doi:10.1212/01.wnl.0000436618.48402.da)

Holmes, M.V. et al. (2013) Secretory phospholipase A2-IIA and cardiovascular disease. Journal of the American College of Cardiology, 62(21), pp. 1966-1976. (doi:10.1016/j.jacc.2013.06.044)

Reil, J., Tardif, J., Ford, I., Lloyd, S.M., O'Meara, E., Komajda, M., Borer, J.S., Tavazzi, L., Swedberg, K., and Böhm, M. (2013) Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. Journal of the American College of Cardiology, 62(21), pp. 1977-1985. (doi:10.1016/j.jacc.2013.07.027)

Witham, M. D., Price, R. J.G., Struthers, A. D., Donnan, P. T., Messow, C.-M., Ford, I., and McMurdo, M. E.T. (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension the VitDISH randomized controlled trial. JAMA Internal Medicine, 173(18), pp. 1672-1679. (doi:10.1001/jamainternmed.2013.9043)

Ruschitzka, F. et al. (2013) Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex. New England Journal of Medicine, 369(15), pp. 1395-1405. (doi:10.1056/NEJMoa1306687)

Fox, K., Bousser, M., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Hennerici, M.G., Mattle, H.P., and Rothwell, P.M. (2013) Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history of ischemic stroke or transient ischemic attack) study population. International Journal of Cardiology, 168(4), pp. 3500-3505. (doi:10.1016/j.ijcard.2013.04.206)

Berry, C. et al. (2013) Fractional flow reserve versus angiography in guiding management to optimize outcomes in non–ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial. American Heart Journal, 166(4), 662-668.e3. (doi:10.1016/j.ahj.2013.07.011)

Fox, K., Ford, I., Steg, P.G., Tardif, J., Tendera, M., and Ferrari, R. (2013) Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure. American Heart Journal, 166(4), 654-661.e6. (doi:10.1016/j.ahj.2013.06.024) (PMID:24093844)

Inglis, S.C. et al. (2013) Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. International Journal of Cardiology, 168(2), pp. 1094-1101. (doi:10.1016/j.ijcard.2012.11.033)

Barry, S. J. E., Dinnett, E., Kean, S., Gaw, A., and Ford, I. (2013) Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland coronary prevention study. PLoS ONE, 8(9), e75379. (doi:10.1371/journal.pone.0075379) (PMID:24058681) (PMCID:PMC3772901)

Ferrari, R., Abergel, H., Ford, I., Fox, K.M., Greenlaw, N., Steg, P.G., Hu, D., Tendera, M., and Tardif, J. (2013) Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. International Journal of Cardiology, 167(6), pp. 2938-2943. (doi:10.1016/j.ijcard.2012.08.013) (PMID:22985742)

Krishnadas, R. et al. (2013) Socioeconomic deprivation and cortical morphology: psychological, social, and biological determinants of ill health study. Psychosomatic Medicine, 75(7), pp. 616-623. (doi:10.1097/PSY.0b013e3182a151a7)

Scott, R.A. et al. (2013) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nature Genetics, 44(9), pp. 991-1005. (doi:10.1038/ng.2385)

Carrick, D. et al. (2013) A randomised controlled trial of deferred stenting versus immediate stenting to prevent no-reflow in acute ST-elevation myocardial infarction. Scottish Medical Journal, 58(3), e41-e41. (doi:10.1177/0036933013495794)

Mooijaart, S.P., Sattar, N., Trompet, S., Lucke, J., Stott, D.J., Ford, I., Jukema, J.W., Westendorp, R.G.J., and de Craen, A.J.M. (2013) Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. Journal of Internal Medicine, 274(1), pp. 77-85. (doi:10.1111/joim.12052)

Smith, B. H. et al. (2013) Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. International Journal of Epidemiology, 42(3), pp. 689-700. (doi:10.1093/ije/dys084)

Berry, C., Lloyd, S.M., Wang, Y., MacDonald, A., and Ford, I. (2013) The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. European Heart Journal, 34(21), pp. 1538-1547. (doi:10.1093/eurheartj/ehs339)

Nanchen, D. et al. (2013) Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study. European Journal of Heart Failure, 15(5), pp. 581-588. (doi:10.1093/eurjhf/hfs195)

Postmus, I., Trompet, S., de Craen, A.J.M., Buckley, B.M., Ford, I., Stott, D.J., Sattar, N., Slagboom, P.E., Westendorp, R.G.J., and Jukema, J.W. (2013) PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population. Journal of Lipid Research, 54(2), pp. 561-566. (doi:10.1194/jlr.P033969)

Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J.R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., and Tavazzi, L. (2013) Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clinical Research in Cardiology, 102(1), pp. 11-22. (doi:10.1007/s00392-012-0467-8)

Komajda, M., Bohm, M., Borer, J., Ford, I., Krum, H., Tase, A., Tavazzi, L., and Swedberg, K. (2013) Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure. European Journal of Heart Failure, 15(1), pp. 79-84. (doi:10.1093/eurjhf/hfs127)

Abrahamsson, P., Swedberg, K., Borer, J.S., Bohm, M., Kober, L., Komajda, M., Lloyd, S.M., Metra, M., Tavazzi, L., and Ford, I. (2013) Risk following hospitalization in stable chronic systolic heart failure. European Journal of Heart Failure, 15(8), pp. 885-891. (doi:10.1093/eurjhf/hft032)

Filippatos, G. et al. (2013) Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. European Journal of Heart Failure, 15(11), pp. 1267-1276. (doi:10.1093/eurjhf/hft099)

Fox, K. et al. (2013) Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. European Heart Journal, 34(29), pp. 2263-2270. (doi:10.1093/eurheartj/eht101)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15(11), pp. 1253-1261. (doi:10.1093/eurjhf/hft085)

Jackson, C.E. et al. (2013) Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply. European Journal of Heart Failure, 14(6), pp. 676-677. (doi:10.1093/eurjhf/hfs050)

Krishnadas, R. et al. (2013) Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: results from the psychological, social and biological determinants of ill health (pSoBid) study. NeuroImage: Clinical, 2(2013), pp. 646-657. (doi:10.1016/j.nicl.2013.04.012)

Lloyd, S.M. et al. (2013) Long-term effects of statin treatment in elderly people: Extended follow-up of the PROspective study of Pravastatin in the elderly at risk (PROSPER). PLoS ONE, 8(9), e72642. (doi:10.1371/journal.pone.0072642)

MacDonald, T.M., Mackenzie, I.S., Wei, L., Hawkey, C.J., and Ford, I. (2013) Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). BMJ Open, 2013(3), e002295. (doi:10.1136/bmjopen-2012-002295)

McCarthy, M.I. et al. (2013) A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genetics, 9(2), e1003266. (doi:10.1371/journal.pgen.1003266)

Millar, K. et al. (2013) Personality, socio-economic status and inflammation: cross-sectional, population-based study. PLoS ONE, 8(3), e58256. (doi:10.1371/journal.pone.0058256)

Reil, J.-C., Robertson, M., Ford, I., Borer, J., Komajda, M., Swedberg, K., Tavazzi, L., and Bohm, M. (2013) Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure. European Journal of Heart Failure, 15(9), pp. 1044-1052. (doi:10.1093/eurjhf/hft072)

Sabayan, B. et al. (2013) Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study. BMJ Open, 347, f4600. (doi:10.1136/bmj.f4600)

Singh, A. et al. (2013) Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations. BMJ Open, 3(12), e004348-e004348. (doi:10.1136/bmjopen-2013-004348)

Stock, S.J., Ferguson, E., Duffy, A., Ford, I., Chalmers, J., and Norman, J.E. (2013) Outcomes of induction of labour in women with previous caesarean delivery: a retrospective cohort study using a population database. PLoS ONE, 8(4), e60404. (doi:10.1371/journal.pone.0060404)

Stuart, W.P., Hussey, K.K., Eifell, R.K.G., Drummond, R., Ford, I., and Welch, G.H. (2013) Using centrally held data to validate carotid surgery outcome data. Stroke, 44(6), pp. 1670-1675. (doi:10.1161/STROKEAHA.111.000200)

Tavazzi, L., Swedberg, K., Komajda, M., Bohm, M., Borer, J.S., Lainscak, M., and Ford, I. (2013) Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study. European Journal of Heart Failure, 15(11), pp. 1296-1303. (doi:10.1093/eurjhf/hft102)

Verschuren, J.J.W. et al. (2013) Non-homologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data. PLoS ONE, 8(2), e56262. (doi:10.1371/journal.pone.0056262)

Welsh, P., Doolin, O., Willeit, P., Packard, C., Macfarlane, P., Cobbe, S., Gudnason, V., Di Angelantonio, E., Ford, I., and Sattar, N. (2013) N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. European Heart Journal, 34(6), pp. 443-450. (doi:10.1093/eurheartj/ehs239)

Witham, M.D., Price, R.J.G., Struthers, A.D., Donnan, P.T., Messow, C., Ford, I., and McMurdo, M.T. (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension. JAMA Internal Medicine, 173(18), pp. 1672-1679. (doi:10.1001/jamainternmed.2013.9043)

2012

McLean, J. et al. (2012) Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations. Behavioural Brain Research, 235(2), pp. 225-230. (doi:10.1016/j.bbr.2012.08.013)

Borer, J.S., Bohm, M., Ford, I., Komajda, M., Tavazzi, L., Sendon, J.L., Alings, M., Lopez-de-Sa, E., and Swedberg, K. (2012) Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. European Heart Journal, 33(22), pp. 2813-2820. (doi:10.1093/eurheartj/ehs259)

Steg, P.G., Greenlaw, N., Tardif, J.-C., Tendera, M., Ford, I., Kaab, S., Abergel, H., Fox, K.M., and Ferrari, R. (2012) Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. European Heart Journal, 33(22), pp. 2831-2840. (doi:10.1093/eurheartj/ehs289)

Miller, A. M. et al. (2012) Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? PLoS ONE, 7(10), e47830. (doi:10.1371/journal.pone.0047830) (PMID:23112853) (PMCID:PMC3480428)

Kaptoge, S. et al. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine, 367(14), pp. 1310-1320. (doi:10.1056/NEJMoa1107477)

Mihaylova, B. et al. (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet, 380(9841), pp. 581-590. (doi:10.1016/S0140-6736(12)60367-5)

Payne, A. R. et al. (2012) Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. Journal of the American Heart Association, 1(4), e002246. (doi:10.1161/JAHA.112.002246)

Hocking, L.J. et al. (2012) Heritability of chronic pain in 2195 extended families. European Journal of Pain, 16(7), pp. 1053-1063. (doi:10.1002/j.1532-2149.2011.00095.x)

Knox, S. et al. (2012) 25-hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis, 223(2), pp. 437-441. (doi:10.1016/j.atherosclerosis.2012.05.001) (PMID:22632919)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308(8), pp. 804-811. (doi:10.1001/jama.2012.8439)

Di Angelantonio, E. et al. (2012) Lipid-related markers and cardiovascular disease prediction. JAMA: Journal of the American Medical Association, 307(23), pp. 2499-2506. (doi:10.1001/jama.2012.6571)

Deshmukh, H.A. et al. (2012) Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a). Journal of Lipid Research, 53(5), pp. 1000-1011. (doi:10.1194/jlr.P021113)

Deshmukh, H.A. et al. (2012) Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importnace of Lp(a). Journal of Lipid Research, 53, pp. 1000-1011. (doi:10.1194/jlr.P021113)

Estrada, K. et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature Genetics, 44(5), pp. 491-501. (doi:10.1038/ng.2249)

Swedberg, K., Komajda, M., Bohm, M., Borer, J., Robertson, M., Tavazzi, L., and Ford, I. (2012) Effects on outcomes of heart rate reduction by Ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose? Findings from the SHIFT (Systolic Heart Failure Treatment with I-f inhibitor ivabradine Trial) Study. Journal of the American College of Cardiology, 59(22), pp. 1938-1945. (doi:10.1016/j.jacc.2012.01.020)

Swerdlow, D.I. et al. (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet, 379(9822), pp. 1214-1224. (doi:10.1016/S0140-6736(12)60110-X)

Nanchen, D. et al. (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 97(3), pp. 852-861. (doi:10.1210/jc.2011-1978)

McGuinness, D. et al. (2012) Socio-economic status is associated with epigenetic differences in the pSoBid cohort. International Journal of Epidemiology, 41(1), pp. 151-160. (doi:10.1093/ije/dyr215)

Rapsomaniki, E., White, I.R., Wood, A.M., Thompson, S.G., and Ford, I. (2012) A framework for quantifying net benefits of alternative prognostic models. Statistics in Medicine, 31(2), pp. 114-130. (doi:10.1002/sim.4362)

Akao, H. et al. (2012) Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly. Atherosclerosis, 220(2), pp. 413-417. (doi:10.1016/j.atherosclerosis.2011.09.028)

Akao, H. et al. (2012) KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly. Atherosclerosis, 220(2), pp. 456-462. (doi:10.1016/j.atherosclerosis.2011.11.037)

Charchar, F.J. et al. (2012) Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet, 379(9819), pp. 915-922. (doi:10.1016/S0140-6736(11)61453-0)

Chasman, D.I. et al. (2012) Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Human Molecular Genetics, 21(24), pp. 5329-5343. (doi:10.1093/hmg/dds369)

Emberson, J.R. et al. (2012) Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS ONE, 7(1), e29849. (doi:10.1371/journal.pone.0029849)

Gibson, G. et al. (2012) Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genetics, 8(3), e1002584. (doi:10.1371/journal.pgen.1002584)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans (MTWA) testing in 'real world' heart failure (HF): a study of prevalence and incremental prognostic value. Heart, 2012(98), A12. (doi:10.1136/heartjnl-2012-301877b.17)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14(6), p. 678. (doi:10.1093/eurjhf/hfs077)

Jackson, C.E. et al. (2012) Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. European Journal of Heart Failure, 14(4), pp. 377-386. (doi:10.1093/eurjhf/hfs010)

Manning, A.K. et al. (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nature Genetics, 44, pp. 659-669. (doi:10.1038/ng.2274)

Poortvliet, R.K.E. et al. (2012) Blood pressure variability and cardiovascular risk in the PROspective study of pravastatin in the elderly at risk (PROSPER). PLoS ONE, 7(12), e52438. (doi:10.1371/journal.pone.0052438)

Shiffman, D. et al. (2012) Genome-wide study of gene variants associated with differential cardiovascular event reduction by Pravastatin therapy. PLoS ONE, 7(5), e38240. (doi:10.1371/journal.pone.0038240)

Steg, P.G., Ferrari, R., Ford, I., Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H., and Fox, K. (2012) Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS ONE, 7(5), e36284. (doi:10.1371/journal.pone.0036284)

Stock, S.J., Ferguson, E., Duffy, A., Ford, I., Chalmers, J., and Norman, J.E. (2012) Outcomes of elective induction of labour compared with expectant management: population based study. British Medical Journal, 344, e2838. (doi:10.1136/bmj.e2838)

Trompet, S., Jukema, W., Mooijaart, S.P., Ford, I., Stott, D.J., Westendorp, R.G.J., and de Craen, A.J.M. (2012) Genetic variation in galectin-3 gene associates with cognitive function at old age. Neurobiology of Aging, 33(9), 2232.e1-2232.e9. (doi:10.1016/j.neurobiolaging.2012.05.001)

Wormser, D. et al. (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. International Journal of Epidemiology, 41(5), pp. 1419-1433. (doi:10.1093/ije/dys086)

2011

Ford, I. et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology, 40(6), pp. 1530-1538. (doi:10.1093/ije/dyr172)

Berry, C., Lloyd, S.M., Wang, Y., MacDonald, A., and Ford, I. (2011) The changing course of aortic valve disease in Scotland: hospitalizations, outcomes and temporal trends. Circulation, 124(21S), A16931.

van Es, A.C.G.M. et al. (2011) Cerebral microbleeds and cognitive functioning in the PROSPER study. Neurology, 77(15), pp. 1446-1452. (doi:10.1212/WNL.0b013e318232ab1d)

Trompet, S. et al. (2011) Replication of LDL SWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses. BMC Medical Genetics, 12, p. 131. (doi:10.1186/1471-2350-12-131)

Welsh, P. et al. (2011) Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arteriosclerosis, Thrombosis and Vascular Biology, 31(10), pp. 2338-2344. (doi:10.1161/ATVBAHA.111.231795) (PMID:21757655)

Ekman, I., Chassany, O., Komajda, M., Bohm, M., Borer, J.S., Ford, I., Tavazzi, L., and Swedberg, K. (2011) Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. European Heart Journal, 32(19), pp. 2395-2404. (doi:10.1093/eurheartj/ehr343)

Mooijaart, S.P. et al. (2011) C-Reactive protein and genetic variants and cognitive decline in old age: the PROSPER Study. PLoS ONE, 6(9), e23890. (doi:10.1371/journal.pone.0023890)

Trew, G. et al. (2011) Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction, 26(8), pp. 2015-2027. (doi:10.1093/humrep/der135)

Bousser, M.G. et al. (2011) Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet, 377(9782), pp. 2013-2022. (doi:10.1016/S0140-6736(11)60600-4)

Widya, R. L. et al. (2011) Increased amygdalar and hippocampal volumes in elderly obese individuals with or at risk of cardiovascular disease. American Journal of Clinical Nutrition, 93(6), pp. 1190-1195. (doi:10.3945/ajcn.110.006304)

Logue, J., Murray, H.M., Welsh, P., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2011) Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart, 97(7), pp. 564-568. (doi:10.1136/hrt.2010.211201)

Rahimi, K. et al. (2011) Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. British Medical Journal, 342, d1250. (doi:10.1136/bmj.d1250)

Tendera, M., Talajic, M., Robertson, M., Tardif, J.-C., Ferrari, R., Ford, I., Steg, P.G., and Fox, K. (2011) Safety of Ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy). American Journal of Cardiology, 107(6), pp. 805-811. (doi:10.1016/j.amjcard.2010.10.065)

Wensley, F. et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ, 342, d548-d548. (doi:10.1136/bmj.d548)

Ceconi, C. et al. (2011) Effect of heart rate reduction by ivabradine on left ventricular remodelling in the echocardiographic substudy of BEAUTIFUL. International Journal of Cardiology, 146(3), pp. 408-414. (doi:10.1016/j.ijcard.2010.10.125)

Wade, A.G., Crawford, G., Ford, I., McConnachie, A., Nir, T., Laudon, M., and Zisapel, N. (2011) Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Current Medical Research and Opinion, 27(1), pp. 87-98. (doi:10.1185/03007995.2010.537317)

Freeman, D. et al. (2011) Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatrics, 11(8), (doi:10.1186/1471-2318-11-8)

Li, Y. et al. (2011) Genetic variants in the KIF6 region and coronary event reduction from statin therapy. Human Genetics, 129(1), pp. 17-23. (doi:10.1007/s00439-010-0892-6)

Macfarlane, P.W., Murray, H., Sattar, N., Stott, D.J., Ford, I., Buckley, B., Jukema, J.W., Westendorp, R.G.J., and Shepherd, J. (2011) The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace, 13(5), pp. 634-639. (doi:10.1093/europace/eur016)

Mutsaerts, H.J.M.M. et al. (2011) Diastolic carotid artery wall shear stress is associated with cerebral infarcts and periventricular white matter lesions. Stroke, 42(12), pp. 3497-3501. (doi:10.1161/STROKEAHA.111.614453)

Packard, C.J. et al. (2011) Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health, 11, p. 42. (doi:10.1186/1471-2458-11-42)

Payne, A.R., Berry, C., Doolin, O., McEntegart, M.B., Robb, S.D., Petrie, M.C., Ford, I., and Oldroyd, K. (2011) Myocardial salvage during primary PCI can be predicted in the cath lab. Heart, 97(Sup. 1), A73-A74. (doi:10.1136/heartjnl-2011-300198.129)

Pons, D. et al. (2011) Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies. Heart, 97(2), pp. 143-150. (doi:10.1136/hrt.2010.199927)

Reil, J.C., Custodis, F., Swedberg, K., Komajda, M., Borer, J.S., Ford, I., Tavazzi, L., Laufs, U., and Bohm, M. (2011) Heart rate reduction in cardiovascular disease and therapy. Clinical Research in Cardiology, 100(1), pp. 11-19. (doi:10.1007/s00392-010-0207-x)

Shiels, P.G. et al. (2011) Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS ONE, 6(7), e22521. (doi:10.1371/journal.pone.0022521)

Smith, N. L. et al. (2011) Genetic predictors of fibrin D-Dimer levels in healthy adults. Circulation, 123(17), pp. 1864-1872. (doi:10.1161/CIRCULATIONAHA.110.009480)

Tardif, J.-C., O'Meara, E., Komajda, M., Bohm, M., Borer, J. S., Ford, I., Tavazzi, L., and Swedberg, K. (2011) Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. European Heart Journal, 32(20), pp. 2507-2515. (doi:10.1093/eurheartj/ehr311)

Van Veldhuisen, D.J. et al. (2011) Intrathroacic impedance monitoring, audible patient alerts and outcome in patients with heart failure. Circulation, 124(16), pp. 1719-1726.

van Veldhuisen, D.J. et al. (2011) Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation, 124(16), pp. 1719-1726. (doi:10.1161/CIRCULATIONAHA.111.043042)

2010

Bohm, M., Swedberg, K., Komajda, M., Borer, J.S., Ford, I., Dubost-Brama, A., Lerebours, G., and Tavazzi, L. (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet, 376(9744), pp. 886-894. (doi:10.1016/S0140-6736(10)61259-7)

Swedkerg, K., Komajda, M., Bohm, M., Borer, J.S., Ford, I., Dubost-Brama, A., Lerebours, G., and Tavazzi, L. (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 376(9744), pp. 875-885. (doi:10.1016/S0140-6736(10)61198-1)

Iakoubova, O.A. et al. (2010) KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study. European Journal of Cardiovascular Prevention and Rehabilitation, 17(4), pp. 455-461. (doi:10.1097/HJR.0b013e328336a0dd)

Ford, I., Robertson, M., Shepherd, J., and Cobbe, S. (2010) Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet, 375(9726), pp. 1634-1639. (doi:10.1016/S0140-6736(10)60545-4)

Caslake, M.J. et al. (2010) Lipoprotein-associated phospholipase A2 inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Atherosclerosis, 210(1), pp. 28-34. (doi:10.1016/j.atherosclerosis.2009.10.041)

Polisecki, E. et al. (2010) Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly. Journal of Lipid Research, 51(5), pp. 1201-1207. (doi:10.1194/jlr.P001172)

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375(9716), pp. 735-742. (doi:10.1016/S0140-6736(09)61965-6)

Parthasarathy, H. K., Alhashmi, K., McMahon, A. D., Struthers, A. D., McInnes, G. T., Ford, I., Connell, J. M., and MacDonald, T. M. (2010) Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO. Journal of Hypertension, 28(1), pp. 170-177. (doi:10.1097/HJH.0b013e328332b79b)

Matthan, N.R., Resteghini, N., Robertson, M., Ford, I., Shepherd, J., Packard, C., Buckley, B.M., Jukema, J.W., Lichenstein, A.H., and Schaefer, E.J. (2010) Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial. Journal of Lipid Research, 51, pp. 202-209. (doi:10.1194/jlr.M900032-JLR200)

Swedberg, K., Komajda, M., Böhm, M., Borer, J.S., Ford, I., and Tavazzi, L. (2010) Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT). European Journal of Heart Failure, 12(1), pp. 75-81. (doi:10.1093/eurjhf/hfp154)

Trompet, S. et al. (2010) Pravastatin and cognitive function in the elderly. Results of the PROSPER study. Journal of Neurology, 257(1), pp. 85-90. (doi:10.1007/s00415-009-5271-7)

Welsh, P. et al. (2010) Unraveling the directional link between adiposity and inflammation: a bidirectional mendelian randomization approach. Journal of Clinical Endocrinology and Metabolism, 95(1), pp. 93-99. (doi:10.1210/jc.2009-1064)

Elliot, H.L., Lloyd, S.M., Ford, I., and Meredith, P.A. (2010) Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk. International Journal of Hypertension, 2010(Articl), (doi:10.4061/2010/490769)

Hennerici, M.G., Bots, M.L., Ford, I., Laurent, S., and Touboul, P.J. (2010) Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history oF ischemic stroke or transient ischemic attack (PERFORM) trial. Cardiovascular Drugs and Therapy, 24(2), pp. 175-180. (doi:10.1007/s10557-010-6231-2)

Preiss, D., Welsh, P., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up(dagger). European Heart Journal, 31(10), pp. 1230-1236. (doi:10.1093/eurheartj/ehq095)

Ray, K. K., Seshasai, S. R. K., Erqou, S., Sever, P., Jukema, J. W., Ford, I., and Sattar, N. (2010) Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants. Archives of Internal Medicine, 170(12), pp. 1024-1031. (doi:10.1001/archinternmed.2010.182)

Sofat, R. et al. (2010) Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation, 121(1), pp. 52-62. (doi:10.1161/CIRCULATIONAHA.109.865444)

Stott, D.J. et al. (2010) Activation of Hemostasis and Decline in Cognitive Function in Older People. Arteriosclerosis, Thrombosis and Vascular Biology, 30(3), pp. 605-611. (doi:10.1161/ATVBAHA.109.199448)

Wade, A.G., Ford, I., Crawford, G., McConnachie, A., Nir, T., Laudon, M., and Zisapel, N. (2010) Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Medicine, 8, p. 51. (doi:10.1186/1741-7015-8-51)

2009

Trompet, S. et al. (2009) Apolipoprotein E genotype, plasma cholesterol, and cancer: a mendelian randomization study. American Journal of Epidemiology, 170(11), pp. 1415-1421. (doi:10.1093/aje/kwp294)

Batty, G.D., Wang, Y., Brouilette, S.W., Shiels, P.G., Packard, C.J., Moore, J., Samani, N.J., and Ford, I. (2009) Socioeconomic status and telomere length: the West of Scotland Coronary Prevention Study. Journal of Epidemiology and Community Health, 63(10), pp. 839-841. (doi:10.1136/jech.2009.088427)

Fox, K., Ford, I., Steg, G., Tendera, M., Robertson, M., and Ferrari, R. (2009) Relationship between Ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. European Heart Journal, 30(19), pp. 2337-2345. (doi:10.1093/eurheartj/ehp358)

Bousser, M.G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M., Mattle, H.P., and Rothwell, P.M. (2009) The prevention of cerebrovascular and cardiovascular events of ischemic origin with Terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study: Baseline characteristics of the population. Cerebrovascular Diseases, 27(6), p. 608. (doi:10.1159/000216835)

Davidson, K.M. et al. (2009) Cognitive behaviour therapy for violent men with antisocial personality disorder in the community: an exploratory randomized controlled trial. Psychological Medicine, 39(4), pp. 569-577. (doi:10.1017/S0033291708004066)

Bousser, M.G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M.G., Mattle, H.P., and Rothwell, P.M. (2009) Rationale and design of a randomized, double-blind, parallel-group study of Terutroban 30 mg/day versus Aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular Diseases, 27(5), p. 509. (doi:10.1159/000212671)

Shepherd, J., Lowe, G., Ford, I., and Robertson, M. (2009) Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Statistics in Medicine, 28(7), pp. 1067-1092. (doi:10.1002/sim.3530)

Stott, D.J., Welsh, P.I., Rumley, A., Robertson, M., Ford, I., Sattar, N.A., Westendorp, R.G.J., Jukema, J.W., Cobbe, S., and Lowe, G.D. (2009) Adipocytokines and risk of stroke in older people: a nested case-control study. International Journal of Epidemiology, 38(1), pp. 253-261. (doi:10.1093/ije/dyn215)

Welsh, P. et al. (2009) Leptin Predicts Diabetes but Not Cardiovascular Disease Results from a large prospective study in an elderly population. Diabetes Care, 32(2), pp. 308-310. (doi:10.2337/dc08-1458)

Deans, K.A. et al. (2009) Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study. British Medical Journal, 339, b4170. (doi:10.1136/bmj.b4170)

Ford, I. et al. (2009) Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Medicine, 6(1), e1000016. (doi:10.1371/journal.pmed.1000016)

Jackson, C.E., Dalzell, J.R., Bezlyak, V., Tsorlalis, I.K., Myles, R.C., Spooner, R., Ford, I., Petrie, M.C., Cobbe, S., and McMurray, J.J. (2009) Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. European Journal of Heart Failure, 11(12), pp. 1152-1154. (doi:10.1093/eurjhf/hfp157)

Sattar, N.A. et al. (2009) Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Medicine, 6(6), e1000099. (doi:10.1371/journal.pmed.1000099)

Sattar, N. et al. (2009) Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia, 52(2), pp. 235-239.

Trompet, S., de Craen, A.J.M., Mooijaart, S., Stott, D.J., Ford, I., Sattar, N.A., Jukema, W., and Westendorp, R.G.J. (2009) High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER study. Clinical Cancer Research, 15(24), pp. 7744-7748. (doi:10.1158/1078-0432.CCR-09-2152)

Watkins, S. et al. (2009) Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation, 120(22), pp. 2207-2213. (doi:10.1161/CIRCULATIONAHA.109.872358)

Weir, R.A.P., Mark, P.B., Petrie, C.J., Clements, S., Steedman, T., Ford, I., Ng, L.L., Squire, I.B., Wagner, G.S., and McMurray, J.J.V. (2009) Left ventricular remodeling after acute myocardial infarction: Does eplerenone have an effect? American Heart Journal, 157(6), pp. 1088-1096. (doi:10.1016/j.ahj.2009.04.001)

2008

Fox, K., Ford, I., Steg, P.G., Tendera, M., and Ferrari, R. (2008) Ivabradine in heart failure: what about digoxin? Lancet, 372(9656), pp. 2113-2114. (doi:10.1016/S0140-6736(08)61924-8)

Fox, K., Ford, I., Steg, P.G., Tendera, M., and Ferrari, R. (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet, 372(9641), pp. 807-816. (doi:10.1016/S0140-6736(08)61170-8)

Fox, K., Ford, I., Steg, P.G., Tendera, M., Robertson, M., and Ferrari, R. (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet, 372(9641), pp. 817-821. (doi:10.1016/S0140-6736(08)61171-X)

Braunschweig, F. et al. (2008) Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). European Journal of Heart Failure, 10(9), pp. 907-916. (doi:10.1016/j.ejheart.2008.06.016)

Polisecki, E. et al. (2008) Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response and cardiovascular disease incidence in PROSPER. Atherosclerosis, 200(1), pp. 109-114.

Ferrari, R., Ford, I., Fox, K., Steg, P.G., and Tendera, M. (2008) The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction – baseline characteristics of the study population. Cardiology, 110(4), pp. 271-282. (doi:10.1159/000112412)

Sattar, N. et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet, 371(9628), pp. 1927-1935. (doi:10.1016/S0140-6736(08)60602-9)

Ford, I., Murray, H., and Cobbe, S. (2008) Long-term follow-up of the West of Scotland Coronary Prevention Study - Reply. New England Journal of Medicine, 358(2), pp. 194-195.

Downs, J.R. et al. (2008) Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet, 371(9607), pp. 117-125. (doi:10.1016/S0140-6736(08)60104-X)

Parthasarathy, H., Alhashmi, K., Struthers, A., Connell, J., McInnes, G., Ford, I., and MacDonald, T. (2008) Does the aldosterone: Renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension: The Renaldo study. Heart, 94, A19-A19.

Poliseckia, E. et al. (2008) Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population. Atherosclerosis, 200(1), pp. 95-101. (doi:10.1016/j.atherosclerosis.2007.12.005)

Stott, D., Falconer, A., Kerr, G., Murray, H., Trompet, S., Westendorp, R., Buckley, B., De Craen, A., Sattar, N., and Ford, I. (2008) Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People? Journal of the American Geriatrics Society, 56(12), pp. 2217-2224. (doi:10.1111/j.1532-5415.2008.02007.x)

Trompet, S. et al. (2008) Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study. Experimental Gerontology, 43(8), pp. 801-805. (doi:10.1016/j.exger.2008.04.006)

Trompet, S. et al. (2008) Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain, 131(4), pp. 1069-1077. (doi:10.1093/brain/awn023)

Velupillai, Y.N. et al. (2008) Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study. BMC Public Health, 8(126), (doi:10.1186/1471-2458-8-126)

Wild, S., Macleod, F., McKnight, J., Watt, G., Mackenzie, C., Ford, I., McConnachie, A., and Lindsay, R. (2008) Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study. Diabetic Medicine, 25(2), pp. 194-199. (doi:10.1111/j.1464-5491.2008.02382.x)

2007

Packard, C.J. et al. (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults. Journal of the American Geriatrics Society, 55(11), pp. 1777-1785. (doi:10.1111/j.1532-5415.2007.01415.x)

Sattar, N., McConnachie, A., Ford, I., Gaw, A., Cleland, S.J., Forouhi, N.G., Macfarlane, P., Shepherd, J., Cobbe, S., and Packard, C. (2007) Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study - Specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes, 56(4), pp. 984-991. (doi:10.2337/db06-1256)

Brouilette, S., Moore, J., McMahon, D., Thompson, J., Ford, I., Shepherd, J., Packard, C., and Samani, N. (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet, 369, pp. 107-114.

Brown, D., Kauermann, G., and Ford, I. (2007) A partial likelihood approach to smooth estimation of dynamic covariate effects using penalised splines. Biometrical Journal, 49, pp. 441-452. (doi:10.1002/bimj.200510325)

Capell, H. et al. (2007) Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Annals of the Rheumatic Diseases, 66, pp. 235-241. (doi:10.1136/ard.2006.057133) (PMID:16926184)

Ford, I., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., and Cobbe, S. (2007) Long-term follow-up of the West of Scotland Coronary Prevention Study. New England Journal of Medicine, 357(15), pp. 1477-1486. (doi:10.1056/NEJMoa065994)

Parthasarathy, H.K., Alhashmi, K., McMahon, A., Struthers, A.D., Connell, J.M.C., McInnes, G.T., Ford, I., and MacDonald, T.M. (2007) Does the aldosterone : renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study. BMC Cardiovascular Disorders, 7(14), (doi:10.1186/1471-2261-7-14)

Ruzyllo, W., Tendera, M., Ford, I., and Fox, K. (2007) Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris - A 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs, 67, pp. 393-405.

Sattar, N. et al. (2007) C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER). Circulation, 115(8), pp. 981-989. (doi:10.1161/CIRCULATIONAHA.106.643114)

Trompet, S. et al. (2007) Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events - The PROSPER study. In: Rattan, S. and Akman, S. (eds.) Biogerontology: Mechanisms and Interventions. Series: Annals of the New York Academy of Sciences (1100). Blackwell Publishing: Oxford, pp. 189-198. ISBN 978-1-57331-679-8 (doi:10.1196/annals.1395.018)

Wade, A., Ford, I., Crawford, G., McMahon, A., Nir, T., Laudon, M., and Zisapel, N. (2007) Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of age sleep and next-day alertness outcomes. Current Medical Research and Opinion, 23, pp. 2597-2605. (doi:10.1185/030079907X233098)

2006

Osman, I., Mackenzie, F., Norrie, J., Murray, H., Greer, I.A., Norman, J.E., and Ford, I. (2006) The 'PRIM' study: a randomized comparison of prostaglandin E2 gel with the nitric donor isosorbide mononitrate for cervical ripening before the induction of labour at term. American Journal of Obstetrics and Gynecology, 194(4), pp. 1012-1021. (doi:10.1016/j.ajog.2005.10.812)

Al Benna, S., Hamilton, C.A., McClure, J.D., Rogers, P.N., Berg, G.A., Ford, I., Delles, C., and Dominiczak, A.F. (2006) Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Arteriosclerosis, Thrombosis and Vascular Biology, 26(1), pp. 218-223. (doi:10.1161/01.ATV.0000193626.22269.45)

Fox, K., Ferrari, R., Tendera, M., Steg, P., Ford, I., and BEAUTIFUL Steering Committee, (2006) Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I-f inhibitor ivabradine in pat. American Heart Journal, 152, pp. 860-866. (doi:10.1016/j.ahj.2006.01.013)

Smith, B.H. et al. (2006) Generation Scotland: the Scottish family health study; a new resource for researching genes and heritability. BMC Medical Genetics, 7, p. 74. (doi:10.1186/1471-2350-7-74)

Walker, A., McMurray, J., Stewart, S., Berger, W., McMahon, A., Dargie, H., Fox, K., Hillis, S., Henderson, N., and Ford, I. (2006) Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart, 92, pp. 619-624. (doi:10.1136/hrt.2003.026385)

Will, M., Bernacca, G., Bell, E., Tolland, M., Lowe, G., Rumley, A., Murray, H., Ford, I., and Wheatley, D. (2006) Our inability to predict thromboembolic events after prosthetic valve surgery. Journal of Heart Valve Disease, 15(4), pp. 570-580.

2005

Tardif, J.-C., Ford, I., Tendera, M., Bourassa, M.G., and Fox, K. (2005) Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. European Heart Journal, 26(23), pp. 2529-2536. (doi:10.1093/eurheartj/ehi586)

Brady, A.J.B., Norrie, J., and Ford, I. (2005) Statin prescribing: is the reality meeting the expectations of primary care? British Journal of Cardiology, 12(5), pp. 397-400.

ten Dam, V.H., van den Heuvel, D.M.J., van Buchem, M.A., Westendorp, R.G.J., Bollen, E.L.E.M., Ford, I., de Craen, A.J.M., and Blauw, G.J. (2005) Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology, 64(10), pp. 1807-1809. (doi:10.1212/01.WNL.0000161844.00797.73)

Brzezinski, A., Vangel, M., Wurtman, R., Norrie, G., Zhdanova, I., Ben-Shushan, A., and Ford, I. (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9, pp. 41-50. (doi:10.1016/j.smrv.2004.06.004)

Dargie, H. et al. (2005) Determinants of coronary events in patients with stable angina: Results from the Impact of Nicorandil in Angina Study. American Heart Journal, 150, (doi:10.1016/j.ahj.2005.03.040)

Kamper, A., Stott, D., Hyland, M., Murray, H., and Ford, I. (2005) Predictors of functional decline in elderly people with vascular risk factors or disease. Age and Ageing, 34, pp. 450-455. (doi:10.1093/ageing/afi137)

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, D., and Ford, I. (2005) Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. Journal of the American College of Cardiology, 45, pp. 525-530.

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, N., and Ford, I. (2005) Antiarrythmic effect of carvedilol after acute myocardial infarction. Journal of the American College of Cardiology, 45(4), pp. 525-530. (doi:10.1016/j.jacc.2004.09.076)

Packard, C.J. et al. (2005) Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation, 112, pp. 3058-3065. (doi:10.1161/CIRCULATIONAHA.105.526848)

Tardif, J., Ford, I., Tendera, M., Bourassa, M., Fox, K., and Initiative Investigators, (2005) Efficacy of ivabradine, a new selective I-f inhibitor, compared with atenolol in patients with chronic stable angina. European Heart Journal, 26, pp. 2529-2536. (doi:10.1093/eurheartj/ehi586)

2004

Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKillop, J.H., and Packard, C.J. (2004) Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. Atherosclerosis Supplements, 5(3), pp. 91-97. (doi:10.1016/j.atherosclerosissup.2004.08.029)

McCarey, D.W., McInnes, I.B., Madhok, R., Hampson, R., Scherbakov, O., Ford, I., Capell, H., and Sattar, N. (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet, 363(9426), pp. 2015-2021. (doi:10.1016/S0140-6736(04)16449-0) (PMID:15207950)

Cleland, J., Findlay, I., Jafri, S., Sutton, G., Falk, R., Bulpitt, C., Prentice, C., Ford, I., Trainer, A., and Poole-Wilson, P. (2004) The Warfarin/Aspirin Study in Heart failure (WASH): A randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal, 148, pp. 157-164. (doi:10.1016/j.ahj.2004.03.010)

Dargie, H. et al. (2004) Impact of nicorandil in angina: subgroup analyses. Heart, 90, pp. 1427-1430. (doi:10.1136/hrt.2003.026310)

Ford, I., Lowe, G.D.O., McMahon, A.D., O'Reilly, D.S., Packard, C.J., and Rumley, A. (2004) Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arteriosclerosis, Thrombosis and Vascular Biology, 24, pp. 1529-1534. (doi:10.1161/01.ATV.0000135995.39488.6c)

Kostis, J.B. et al. (2004) Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 11(1), pp. 9-17.

Lees, K.R. et al. (2004) Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet, 363, pp. 439-445.

Sattar, N., Scherbakova, O., Ford, I., O'Reilly, D., Stanley, A., Forrest, E., MacFarlane, P., Packard, C., Cobbe, S., and Shepherd, J. (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes, 53(11), pp. 2855-2860. (doi:10.2337/diabetes.53.11.2855)

Sattar, N. et al. (2004) Metabolic syndrome and diabetes mellitus - Response. Circulation, 109(3), E23-E23.

2003

O'Dwyer, P.J. et al. (2003) Local or general anesthesia for open hernia repair: a randomized trial. Annals of Surgery, 237(4), pp. 574-579.

Daly, C., Norrie, J., Murdoch, D., Ford, I., Dargie, H., and Fox, K. (2003) The value of routine non-invasive tests to predict clinical outcome in stable angina. European Heart Journal, 24, pp. 534-542. (doi:10.1016/S0195-668X(02)00820-5)

Pell, J., Sirel, J., Marsden, A., Ford, I., Walker, N., and Cobbe, S. (2003) Presentation, management, and outcome of out of hospital cardiopulmonary arrest: comparison by underlying aetiology. Heart, 89(8), pp. 839-842. (doi:10.1136/heart.89.8.839)

Pell, J., Sirel, J., Walker, N., Cobbe, S., Marsden, A., and Ford, I. (2003) Public access defibrillators - Defibrillators in public places save lives - Reply. British Medical Journal, 326(7381), p. 163.

Sattar, N. et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108(4), pp. 414-419. (doi:10.1161/01.CIR.0000080897.52664.94)

2002

Avorn, J. et al. (2002) Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Controlled Clinical Trials, 23, pp. 757-773.

Dargie, H., Ford, I., Fox, K., and Hillis, W. (2002) Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet, 359, pp. 1269-1275.

Ford, I. et al. (2002) A prospective study of pravastatin in the elderly at risk (PROSPER): Screening experience and baseline characteristics. Current Controlled Trials in Cardiovascular Medicine, 3, p. 8. (doi:10.1186/1468-6708-3-8)

Ford, I., and Norrie, J. (2002) The role of covariates in estimating treatment effects and risk in long-term clinical trials. Statistics in Medicine, 21, pp. 2899-2908. (doi:10.1002/sim.1294)

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D. S. J.,, Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600. (doi:10.2337/diabetes.51.5.1596)

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D.S., Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600.

Houx, P.J. et al. (2002) Testing cognitive function in elderly populations: the PROSPER study. Journal of Neurology, Neurosurgery and Psychiatry, 73(4), pp. 385-389. (doi:10.1136/jnnp.73.4.385)

Kostis, J. et al. (2002) Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. American Journal of Hypertension, 15(2), pp. 193-198. (doi:S0895-7061(01)02048-9)

Otterstad, J., and Ford, I. (2002) The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction - How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-bl. European Journal of Heart Failure, 4, pp. 501-506.

Shepherd, J. et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 360(9346), pp. 1623-1630. (doi:10.1016/S0140-6736(02)11600-X)

Simes, J., Furberg, C., Braunwald, E., Davis, B., Ford, I., Tonkin, A., and Shepherd, J. (2002) Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels - The Prospective Pravastatin Pooling project. European Heart Journal, 23, pp. 207-215. (doi:10.1053/euhj.2001.2775)

Streja, L., Packard, C., Shepherd, J., Cobbe, S., and Ford, I. (2002) Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS). American Journal of Cardiology, 90(7), pp. 731-736. (doi:10.1016/S0002-9149(02)02599-7)

2001

Blue, L. et al. (2001) Randomised controlled trial of specialist nurse intervention in heart failure. British Medical Journal, 323, pp. 715-718. (doi:10.1136/bmj.323.7315.715)

Freeman, D. et al. (2001) Pravastatin and the development of diabetes mellitus - Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 103(3), pp. 357-362.

McDonagh, T., Cunningham, A., Morrison, C., McMurray, J., Ford, I., Morton, J., and Dargie, H. (2001) Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart, 86, pp. 21-26.

Pell, J.P., Sirel, J.M., Marsden, A.K., Ford, I., and Cobbe, S.M. (2001) Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. British Medical Journal, 322, pp. 1385-1388. (doi:10.1136/bmj.322.7299.1385)

2000

Packard, C.J. et al. (2000) Lipoprotein-associated phospholipse A2 as an independent predictor of coronary heart disease (WOSCOPS). New England Journal of Medicine, 343(16), pp. 1148-1155. (doi:10.1056/NEJM200010193431603)

L'Itallien, G., Ford, I., Norrie, J., LaPuerta, P., Ehreth, J., Jackson, J., and Shepherd, J. (2000) The cardiovascular event reduction tool(CERT)- a simplified cardiac risk prediction model developed fron the West of Scotland coronary prevention study (WOSCOPS). American Journal of Cardiology, 85(6), pp. 720-724. (doi:10.1016/S0002-9149(99)00847-4)

Gaw, A., Brown, E.A., Docherty, G., and Ford, I. (2000) Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? a nested case control study from the West of Scotland coronary prevention study. Atherosclerosis, 148(1), pp. 95-100. (doi:10.1016/S0021-9150(99)00259-2)

Lowe, G., Rumley, A., Norrie, J., Ford, I., Shepherd, J., Cobbe, S., Macfarlane, P., and Packard, C. (2000) Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thrombosis and Haemostasis, 84(4), pp. 553-558.

Packard, C.J. et al. (2000) Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease. New England Journal of Medicine, 343(16), pp. 1148-1155.

Pell, J., Pell, A.C.H., Norrie, J., Ford, I., and Cobb, S.M. (2000) Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. British Medical Journal, 320, pp. 15-18. (doi:10.1136/bmj.320.7226.15)

1999

Gaw, A., Brown, E.D., Docherty, G., and Ford, I. (1999) Use of the West of Scotland coronary prevention study bio-bank to provide new insights into the control of plasma lipoprotein(a) concentrations. Biochemical Society Transactions, 27(4), pp. 459-463.

Gaw, A., Docherty, G., Brown, E., and Ford, I. (1999) Predictors of plasma lipoprotein(a) concentration in the West of Scotland coronary prevention study cohort. Atherosclerosis, 143(2), pp. 445-450. (doi:10.1016/S0021-9150(98)00305-0)

Cleland, J.G.F. et al. (1999) The WASH study (warfarin/aspirin study in heart failure) rationale, design and end-points. European Journal of Heart Failure, 1(1), pp. 95-99.

1998

Packard, C., Shepherd, J., Cobbe, S., Ford, I., Isles, C.G., McKillop, J.H., MacFarlane, P.W., Lorimer, A.R., and Norrie, J. (1998) Influence of pravastatin and plasma lipids on clinical events in the West of Scotland coronary prevention study (WOSCOPS). Circulation, 97(15), pp. 1440-1445.

McDonagh, T., Robb, S.D., Murdoch, D.R., Morton, J.J., Ford, I., Morrison, C.E., Tunstall-Pedoe, H., McMurray, J., and Dargie, H. (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet, 351(9095), pp. 9-13. (doi:10.1016/S0140-6736(97)03034-1)

Ford, I., and Holmes, A.P. (1998) Functional neuroimaging and statistics. In: Everitt, B.S. and Dunn, G. (eds.) In Statistical Analysis of Medical Data: New Developments. Oxford University Press: London, UK, pp. 277-305. ISBN 9780340677759

Gaw, A., Brown, E., and Ford, I. (1998) Impact of Aapo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect. Arteriosclerosis, Thrombosis and Vascular Biology, 18, pp. 1870-1876. (doi:10.1161/01.ATV.18.12.1870)

1997

Caro, J., Klittoch, W., McGuire, A., Ford, I., Norrie, J., Pettitt, D., McMurray, J., and Shepherd, J. (1997) The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. British Medical Journal, 315, pp. 1577-1582. (doi:10.1136/bmj.315.7122.1577)

McDonagh, T.A., Morrison, C.E., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J.J.V., and Dargie, H.J. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet, 350(9081), pp. 829-833. (doi:10.1016/S0140-6736(97)03033-X)

1996

Patel, D.J., Mulcahy, D., Norrie, J., Wright, C., Clarke, D., Ford, I., and Fox, K.M. (1996) Natural variability of transient myocardial ischaemia during daily life: an obstacle when assessing efficacy of anti-ischaemic agents? Heart, 76, pp. 477-482.

Cobbe, S.M., Dalziel, K., Ford, I., and Marsden, A.K. (1996) Survival of 1476 patients initally resuscitated from out-of-hospital cardiac-arrest. British Medical Journal, 312, pp. 1633-1637. (doi:10.1136/bmj.312.7047.1633)

Fox, K.M., Mulcahy, D., Findlay, I., Ford, I., and Dargie, H. (1996) The Total Ischaemic Burden European Trial (TIBET): effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. European Heart Journal, 17(1), pp. 96-103.

Fox, K.M., Mulcahy, D., Findlay, I., Ford, I., and Dargie, H. (1996) Total Ischaemic Burden European Trial (TIBET): effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. European Heart Journal, 17(1), pp. 104-112.

Holmes, A.P., Blair, R.C., Watson, J.D., and Ford, I. (1996) Nonparametric analysis of statistic images from functional mapping experiments. Journal of Cerebral Blood Flow and Metabolism, 16, pp. 7-22. (doi:10.1097/00004647-199601000-00002)

1995

Patel, D.J., Mulcahy, D., Norrie, J., Sparrow, J., Wright, C., Ford, I., and Fox, K.M. (1995) Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy? European Heart Journal, 16(12), pp. 1773-1779.

Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., Macfarlane, P.W., McKillop, J.H., and Packard, C.J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine, 333(20), pp. 1301-1308. (doi:10.1056/NEJM199511163332001)

Ford, I. (1995) Some nonontological and functionally unconnected views on current issues in the analysis of PET datasets. Journal of Cerebral Blood Flow and Metabolism, 15(3), pp. 371-377. (doi:10.1038/jcbfm.1995.46)

Ford, I., Norrie, J., and Ahmadi, S. (1995) Model inconsistency, illustrated by Cox proportional hazards model. Statistics in Medicine, 14(8), pp. 735-746. (doi:10.1002/sim.4780140804)

Martin, B.J., Devine, B.L., MacDonald, J.B., Williams, J., Kiggins, P., Norrie, J., and Ford, I. (1995) Incidence of pressure sores in geriatric long-term hospital care. Journal of Tissue Viability, 5, pp. 83-88.

Metcalfe, M., and Ford, I. (1995) Contribution of perindopril in the treatment of congestive heart failure. Drugs of Today, 31, pp. 39-44.

1994

McColl, J.H., Holmes, A.P., and Ford, I. (1994) Statistical methods in neuroimaging with particular application to emission tomography. Statistical Methods in Medical Research, 3(1), pp. 63-86.

1993

Ray, S.G., Pye, M., Oldroyd, K.G., Christie, J., Connelly, D., Norhtridge, D., Morton, J.J., Ford, I., Dargie, H., and Cobbe, S. (1993) Early treatment with Captopril after acute myocardial infarction. British Heart Journal, 69(3), pp. 215-222.

Dargie, H., Fox, K.M., and Ford, I. (1993) Clinical trials in silent ischaemia: lessons from TIBET. Archives de Maladies du Coeur et des Vaisseaux, 86, pp. 31-34.

Graham, D.I., Adams, J.H., Doyle, D., Ford, I., Gennarelli, T.A., Lawrence, A.E., Maxwell, W.L., and McLean, D.R. (1993) Quantification of primary and secondary lesions in severe head injury. Acta Neurochirurgica: Supplementum, 57, pp. 41-48.

1992

Ford, I., Torsney, B., and Wu, C.F.J. (1992) The use of a canonical form in the construction of locally optimal designs for non-linear problems. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 54(2), pp. 569-583.

1991

McCrory, S.J., and Ford, I. (1991) Multivariate analysis of SPECT images with illustrations in Alzheimer's disease. Statistics in Medicine, 10(11), pp. 1711-1718.

Oldroyd, K.G., Pye, M.P., Ray, S.G., Christie, J., Ford, I., Cobbe, S.M., and Dargie, H.J. (1991) Effects of early Captopril administration on infarct expansion, left ventricular remodelling and exercise capacity after acute myocardial infarction. American Journal of Cardiology, 68(8), pp. 713-718. (doi:10.1016/0002-9149(91)90641-W)

Ford, I., McColl, J.H., McCormack, A.G., and McCrory, S.J. (1991) Statistical issues in the analysis of neuroimages. Journal of Cerebral Blood Flow and Metabolism, 11(2), A89-A95.

McLenachan, J.M., Grant, S., Ford, I., Henderson, E., and Dargie, H.J. (1991) Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during tredmill excerise: a study of Celiprolol and Atenolol. American Heart Journal, 121(2), pp. 691-696.

Ford, I. (1991) Angina clinical trial methodology. Postgraduate Medical Journal, 67(Sup 3), S2-S8.

Kerr, W.J.S., and Ford, I. (1991) The variability of some craniofacial dimensions. Angle Orthodontist, 61(3), pp. 205-210.

Kotapka, M.J., Gennarelli, T.A., Graham, D.I., Adams, J.H., Thibault, L.E., Ross, D.T., and Ford, I. (1991) Selective vulnerability of hippocampal neurons in acceleration-induced experimental head injury. Journal of Neurotrauma, 8(4), pp. 247-258.

1990

Pickard, M.A., Venner, R.M., Ford, I., and Todd, B.D. (1990) The influence of immediate physiotherapy in the out-patient management of acute knee injuries: a controlled study. Archives of Emergency Medicine, 7(4), pp. 249-252.

Northbridge, D.B., Grant, S., Ford, I., Christie, J., McLenachan, J., Connelly, D., McMurray, J., Ray, S., Henderson, E., and Dargie, H.J. (1990) Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer. British Heart Journal, 64(5), pp. 313-316.

Hirst, D.J., Ford, I., and Critchley, F. (1990) An empirical investigation of methods for interval estimation of the log odds ratio in discriminant analysis. Biometrika, 77(3), pp. 609-615.

1989

Adams, J.H., Doyle, D., Ford, I., Gennarelli, T.A., Graham, D.I., and McLellan, D.R. (1989) Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology, 15(1), pp. 49-59. (doi:10.1111/j.1365-2559.1989.tb03040.x)

Adams, J.H., Doyle, D., Ford, I., Graham, D.I., McGee, M., and McLellan, D.R. (1989) Brain damage in fatal non-missile head injury in relation to age and type of injury. Scottish Medical Journal, 34(1), pp. 399-401.

Graham, D.I., Ford, I., Adams, J.H., Doyle, D., Lawerence, A.E., and McLellan, D.R. (1989) Fatal head injury in children. Journal of Clinical Pathology, 42(1), pp. 18-22.

Graham, D.I., Ford, I., Adams, J.H., Doyle, D., Teasdale, F.M., Lawrence, A.E., and McLellan, D.R. (1989) Ischaemic brain damage is still common in fatal non-missile head injury. Journal of Neurology, Neurosurgery and Psychiatry, 52(3), pp. 346-350. (doi:10.1136/jnnp.52.3.346)

McColl, J.H., Ford, I., McGhee, M.A., Brooks, D.N., and Murphy, J.B. (1989) Referal patterns of elderly patients with dementia or depression. Health Bulletin, 47(6), pp. 273-281.

Ng, T., Graham, D.I., Adams, J.H., and Ford, I. (1989) Changes in the hippocampus and the cerebellum resulting from hypoxic insults: frequency & distribution. Acta Neuropathologica, 78(4), pp. 438-443. (doi:10.1007/BF00688181)

1988

Critchley, F., Ford, I., and Rijal, O. (1988) Interval estimation based on the profile likelihood: strong Lagrangrain theory, with applications to discrimination. Biometrika, 75(1), pp. 21-28.

1987

Dargie, H.J., Cleland, J.G.F., Leckie, B.J., Inglis, G.G., East, B.W., and Ford, I. (1987) The relation of arythmmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation, 75(5), pp. 98-107.

Osbourne, K.A., Shigeno, T., Balarsky, A.M., Ford, I., McCulloch, J., Teasdale, G.M., and Graham, D.I. (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. Journal of Neurology, Neurosurgery and Psychiatry, 50(4), pp. 402-410.

Cleland, J.G., Dargie, H.J., and Ford, I. (1987) Mortality in heart failure: clinical variables of prognostic value. British Heart Journal, 58(6), pp. 572-582.

1986

Wrona, F.J., Calow, P., Ford, I., Baird, D.J., and Maltby, L. (1986) Estimating the abundance of stone dwelling organisms: A new method. Canadian Journal of Fisheries and Aquatic Sciences, 43(10), pp. 2025-2035. (doi:10.1139/f86-248)

Kelly, P.A.T., Ford, I., and McCulloch, J. (1986) The effect of diazepam upon local cerebral glucose use in the conscious rat. Neuroscience, 19(1), pp. 257-265. (doi:10.1016/0306-4522(86)90019-9)

Ford, I. (1986) Confunded correlations: statistical limitations in the analysis of interregional relationships of cerebral metabolic activity. Journal of Cerebral Blood Flow and Metabolism, 6(3), pp. 385-388.

Kerr, W.J.S., and Ford, I. (1986) A comparison of facial form in three Western European male groups. European Journal of Orthodontics, 8(2), pp. 106-111.

1985

Cleland, J.G.F., Dargie, H., McAlpine, H., Ball, S.G., Morton, J.J., Robertson, J.I.S., and Ford, I. (1985) Severe hypotension after 1st dose of Enalapril in heart failure. British Medical Journal, 291(6505), pp. 1309-1312.

Cleland, J.G.F., Dargie, H., Ball, S.G., Gillen, G., Hodsman, G.P., Morton, J.J., East, B.W., Robertson, I., Ford, I., and Robertson, J.I.S. (1985) Effects of Enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones and metabolic state. Heart, 54(3), pp. 305-312.

Critchley, F., and Ford, I. (1985) Interval estimation in discrimination: the multivariate normal equal covariance case. Biometrika, 72(1), pp. 109-116. (doi:10.2307/2336340)

Ford, I., Titterington, D., and Wu, C.F.J. (1985) Inference and sequential design. Biometrika, 72(3), pp. 545-551. (doi:10.2307/2336726)

1984

Critchley, F., and Ford, I. (1984) On the covariance of 2 noncentral F-random variable and the variance of the estimated linear discriminant function. Biometrika, 71(3), pp. 637-368. (doi:10.2307/2336578)

Cleland, J., Semple, P., Ball, S., Ford, I., Dargie, H., and Hodsman, P. (1984) Angiotensin II levels, hemodynamics and sympathoadrenal function after low-dose Captopril in heart failure. American Journal of Medicine, 77(5), pp. 880-886. (doi:10.1016/0002-9343(84)90530-8)

1983

Smith, N., Soutter, W.P., Sharp, F., McColl, J., and Ford, I. (1983) Fetal scalp blood lactate as an indicator of intrapartum hypoxia. British Journal of Obstetrics and Gynaecology, 90(9), pp. 821-831. (doi:10.1111/j.1471-0528.1983.tb09322.x)

1982

McCulloch, J., Kelly, P.A.T., and Ford, I. (1982) Effect of Apomorphine on the relationship between local cerebral glucose-utilization and local cerebral blood-flow (with an appendix on its statistical-analysis). Journal of Cerebral Blood Flow and Metabolism, 2(4), pp. 487-499. (doi:10.1038/jcbfm.1982.56)

1980

Ford, I., and Silvey, S.D. (1980) A sequentially constructed design for estimating a nonlinear parametric function. Biometrika, 67(2), pp. 381-388. (doi:10.1093/biomet/67.2.381)

This list was generated on Fri May 27 07:22:59 2016 BST.
Number of items: 388.

Articles

Carrick, D. et al. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1(6), e85768. (doi:10.1172/jci.insight.85768)

Lee, M. M.Y. et al. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS). Open Heart, 3(1), e000371. (doi:10.1136/openhrt-2015-000371) (PMID:27110377) (PMCID:PMC4838768)

Carrick, D. et al. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37(13), pp. 1044-1059. (doi:10.1093/eurheartj/ehv372) (PMID:26261290)

Gonzalez-Valcarcel, J. et al. (2016) Paracetamol, ibuprofen, and recurrent major cardiovascular and major bleeding events in 19 120 patients with recent ischemic stroke. Stroke, 47(4), pp. 1045-1052. (doi:10.1161/strokeaha.115.012091) (PMID:26979864)

Trompet, S. et al. (2016) Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies. European Journal of Clinical Pharmacology, 72(4), pp. 431-437. (doi:10.1007/s00228-015-1994-9) (PMID:26686871)

Elliott, H. L., Lloyd, S. M., Ford, I., and Meredith, P. (2016) Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system. Blood Pressure, 25(2), pp. 67-73. (doi:10.3109/08037051.2015.1127526) (PMID:26796694)

Meredith, P. A., Lloyd, S. M., Ford, I., and Elliott, H. L. (2016) Importance of sustained and “tight” blood pressure control in patients with high cardiovascular risk. Blood Pressure, 25(2), pp. 74-82. (doi:10.3109/08037051.2015.1127528)

Clarke, A. T., Johnson, P. C.D., Hall, G. C., Ford, I., and Mills, P. (2016) High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort. PLoS ONE, 11(3), e0151587. (doi:10.1371/journal.pone.0151587) (PMID:26983033)

Pisano, U., Deosaran, J., Leslie, S. J., Rushworth, G. F., Stewart, D., Ford, I., and Watson, A. J. M. (2016) Nicorandil, gastrointestinal adverse drug reactions and ulcerations: a systematic review. Advances in Therapy, 33(3), pp. 320-344. (doi:10.1007/s12325-016-0294-9) (PMID:26861848)

Kilpeläinen, T. O. et al. (2016) Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nature Communications, 7, 10494. (doi:10.1038/ncomms10494) (PMID:26833098) (PMCID:PMC4740377)

Brown, M. J. et al. (2016) Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes and Endocrinology, 4(2), pp. 136-147. (doi:10.1016/s2213-8587(15)00377-0) (PMID:26489809) (PMCID:PMC4728199)

Carrick, D. et al. (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-elevation myocardial infarction: pathophysiologic insights and clinical implications. Journal of the American Heart Association, 5, e002834. (PMID:26908408)

Ibrahim-Verbaas, C. A. et al. (2016) GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Molecular Psychiatry, 21(2), pp. 189-197. (doi:10.1038/mp.2015.37) (PMID:25869804) (PMCID:PMC4722802)

Gorcsan, J. et al. (2016) Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial. European Heart Journal, 37(1), pp. 49-59. (doi:10.1093/eurheartj/ehv418) (PMID:26321238)

Carberry, J. et al. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, (Accepted for Publication)

Carrick, D. et al. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9(1), e004148. (doi:10.1161/CIRCIMAGING.115.004148)

Dehghan, A. et al. (2016) Genome wide association study for incident myocardial infarction and coronary heart disease in prospective cohort studies: the CHARGE consortium. PLoS ONE, 11(3), e0144997. (doi:10.1371/journal.pone.0144997) (PMID:26950853) (PMCID:PMC4780701)

Ford, I., Murray, H., Mccowan, C., and Packard, C. J. (2016) Long term safety and efficacy of lowering LDL cholesterol with statin therapy: 20-year follow-up of West of Scotland coronary prevention study. Circulation, (doi:10.1161/CIRCULATIONAHA.115.019014) (Early Online Publication)

Lawson, K., Briggs, A., Lewsey, J., Ford, I., Watt, G., Tunstall-Pedoe, H., Woodward, M., Ritchie, L., Kent, S., and Neilson, M. (2016) A cardiovascular disease policy model: part 2 – preparing for economic evaluation and to assess health inequalities. Open Heart, (Accepted for Publication)

Leslie, W. S. et al. (2016) The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Family Practice, 17(1), (doi:10.1186/s12875-016-0406-2) (PMID:26879684) (PMCID:PMC4754868)

Tendera, M., Chassany, O., Ferrari, R., Ford, I., Steg, P. G., Tardif, J.-C., and Fox, K. (2016) Quality of life with ivabradine in patients with angina pectoris. Circulation: Cardiovascular Quality and Outcomes, (doi:10.1161/circoutcomes.115.002091) (PMID:26696613) (Early Online Publication)

Böhm, M., Robertson, M., Ford, I., Borer, J. S., Komajda, M., Kindermann, I., Maack, C., Lainscak, M., Swedberg, K., and Tavazzi, L. (2015) Influence of cardiovascular and noncardiovascular co-morbidities on outcomes and treatment effect of heart rate reduction With Ivabradine in stable heart failure (from the SHIFT Trial). American Journal of Cardiology, 116(12), pp. 1890-1897. (doi:10.1016/j.amjcard.2015.09.029) (PMID:26508709)

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., and Ferrari, R. (2015) Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. European Heart Journal, 36(46), pp. 3291-3296. (doi:10.1093/eurheartj/ehv451) (PMID:26385957)

Komajda, M., Tavazzi, L., Francq, B., Böhm, M., Borer, J. S., Ford, I., and Swedberg, K. (2015) Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial. European Journal of Heart Failure, 17(12), pp. 1294-1301. (doi:10.1002/ejhf.347) (PMID:26377342)

Packard, C., and Ford, I. (2015) Long-term follow-up of lipid-lowering trials. Current Opinion in Lipidology, 26(6), pp. 572-579. (doi:10.1097/mol.0000000000000230)

Williams, B. et al. (2015) Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet, 386(10008), pp. 2059-2068. (doi:10.1016/S0140-6736(15)00257-3) (PMID:26414968) (PMCID:PMC4655321)

Hofer, E. et al. (2015) White matter lesion progression: genome-wide search for genetic influences. Stroke, 46(11), pp. 3048-3057. (doi:10.1161/STROKEAHA.115.009252) (PMID:26451028)

Rogers, J. K., Kielhorn, A., Borer, J. S., Ford, I., and Pocock, S. J. (2015) Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients. Current Medical Research and Opinion, 31(10), pp. 1903-1909. (doi:10.1185/03007995.2015.1080155) (PMID:26361063)

Hamill, V. et al. (2015) Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction. American Journal of Medicine, 128(10), 1102-1108.e6. (doi:10.1016/j.amjmed.2015.04.042) (PMID:26044936)

Nikpay, M. et al. (2015) A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease. Nature Genetics, 47(10), pp. 1121-1130. (doi:10.1038/ng.3396) (PMID:26343387)

Gumley, A. et al. (2015) A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for Depression After Psychosis: A Pilot Trial Protocol (ADAPT). Psychosis, pp. 1-13. (doi:10.1080/17522439.2015.1100669)

Morris, R. W. et al. (2015) Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium: Table 1. BMJ Open, 5(8), e008808. (doi:10.1136/bmjopen-2015-008808) (PMID:26264275) (PMCID:PMC4538266)

Steffel, J. et al. (2015) The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. European Heart Journal, 36(30), pp. 1983-1989. (doi:10.1093/eurheartj/ehv242) (PMID:26009595)

Joshi, P. K. et al. (2015) Directional dominance on stature and cognition in diverse human populations. Nature, 523(7561), pp. 459-462. (doi:10.1038/nature14618) (PMID:26131930)

Bocchi, E. A., Bohm, M., Borer, J.S., Ford, I., Komajda, M., Swedberg, K., and Tavazzi, L. (2015) Effect of combining ivabradine and β-blockers: focus on the use of carvedilol in the SHIFT population. Cardiology, 131(4), pp. 218-224. (doi:10.1159/000380812) (PMID:25968495)

Carrick, D. et al. (2015) Pathophysiology of LV remodeling in survivors of STEMI : inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging, 8(7), pp. 779-789. (doi:10.1016/j.jcmg.2015.03.007) (PMID:26093923) (PMCID:PMC4509710)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, 36(24), pp. 1536-1546. (doi:10.1093/eurheartj/ehv072) (PMID:25802390)

Böhm, M. et al. (2015) Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy. European Journal of Heart Failure, 17(5), pp. 518-526. (doi:10.1002/ejhf.258) (PMID:25801408)

Ford, I. (2015) Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet, 385(9976), pp. 1397-1405. (doi:10.1016/S0140-6736(14)61368-4)

Ford, I., Robertson, M., Komajda, M., Böhm, M., Borer, J. S., Tavazzi, L., and Swedberg, K. (2015) Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: the SHIFT risk model. International Journal of Cardiology, 184, pp. 163-169. (doi:10.1016/j.ijcard.2015.02.001) (PMID:25703424)

Huang, X., Cheripelli, B. K., Lloyd, S. M., Kalladka, D., Moreton, F. C., Siddiqui, A., Ford, I., and Muir, K. W. (2015) Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST): phase 2 randomised clinical trial. Lancet Neurology, 14(4), pp. 368-376. (doi:10.1016/S1474-4422(15)70017-7) (PMID:25726502)

Zimmermann, E. et al. (2015) Is the adiposity-associatedFTOgene variant related to all-cause mortality independent of adiposity? Meta-analysis of data from 169,551 Caucasian adults. Obesity Reviews, 16(4), pp. 327-340. (doi:10.1111/obr.12263)

Borer, J. S., Böhm, M., Ford, I., Komajda, M., Swedberg, K., and Tavazzi, L. (2015) Effect of ivabradine on early readmissions after hospitalization for worsening heart failure. JACC: Heart Failure, 3(3), pp. 268-269. (doi:10.1016/j.jchf.2014.12.004) (PMID:25742766)

Campbell, R. T. et al. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2(1), pp. 25-36. (doi:10.1002/ehf2.12027)

Ponikowski, P. et al. (2015) The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. European Journal of Heart Failure, 17(3), pp. 329-339. (doi:10.1002/ejhf.229) (PMID:25683972) (PMCID:PMC4413361)

Wijsman, L. W., de Craen, A. J.M., Muller, M., Sabayan, B., Stott, D., Ford, I., Trompet, S., Jukema, J. W., Westendorp, R. G.J., and Mooijaart, S. P. (2015) Blood pressure lowering medication, visit-to-visit blood pressure variability, and cognitive function in old age. American Journal of Hypertension, 29(3), pp. 311-318. (doi:10.1093/ajh/hpv101) (PMID:26156873)

Shungin, D. et al. (2015) New genetic loci link adipose and insulin biology to body fat distribution. Nature, 518(7538), pp. 187-196. (doi:10.1038/nature14132) (PMID:25673412) (PMCID:PMC4338562)

Davies, G. et al. (2015) Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949). Molecular Psychiatry, 20(2), pp. 183-192. (doi:10.1038/mp.2014.188) (PMID:25644384) (PMCID:PMC4356746)

Pers, T. H. et al. (2015) Biological interpretation of genome-wide association studies using predicted gene functions. Nature Communications, 6, p. 5890. (doi:10.1038/ncomms6890) (PMCID:PMC4420238)

Layland, J. et al. (2015) Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. European Heart Journal, 36(2), pp. 100-111. (doi:10.1093/eurheartj/ehu338) (PMID:25179764) (PMCID:PMC4291317)

Swerdlow, D. I. et al. (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet, 385(9965), pp. 351-361. (doi:10.1016/S0140-6736(14)61183-1) (PMID:25262344) (PMCID:PMC4322187)

Bis, J. C. et al. (2015) Drug-gene interactions of antihypertensive medications and risk of incident cardiovascular disease: a pharmacogenomics study from the CHARGE consortium. PLoS ONE, 10(10), e0140496. (doi:10.1371/journal.pone.0140496) (PMID:26516778) (PMCID:PMC4627813)

Brown, M. J. et al. (2015) Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension. BMJ Open, 5(8), e008086. (doi:10.1136/bmjopen-2015-008086) (PMID:26253567) (PMCID:PMC4539390)

Carrick, D. et al. (2015) Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), Q:52. (doi:10.1186/1532-429X-17-S1-Q52) (PMCID:PMC4328295)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O54. (doi:10.1186/1532-429X-17-S1-O54) (PMCID:PMC4328590)

Carrick, D. et al. (2015) Prognostic significance of quantitative measures of myocardial infarct pathology using native T1 mapping, in survivors of ST-elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O53. (doi:10.1186/1532-429X-17-S1-O53) (PMCID:PMC4328908)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by non-contrast T1 mapping cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O26. (doi:10.1186/1532-429X-17-S1-O26) (PMCID:PMC4328668)

Chaker, L. et al. (2015) Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. Journal of Clinical Endocrinology and Metabolism, 100(6), pp. 2181-2191. (doi:10.1210/jc.2015-1438) (PMID:25856213)

Cook, J. A. et al. (2015) Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers. Trials, 16(1), 12. (doi:10.1186/s13063-014-0526-8) (PMID:25928502) (PMCID:PMC4302137)

Fauchier, L., Greenlaw, N., Ferrari, R., Ford, I., Fox, K. M., Tardif, J.-C., Tendera, M., and Steg, P. G. (2015) Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry. PLoS ONE, 10(4), e0125164. (doi:10.1371/journal.pone.0125164) (PMID:25915904) (PMCID:PMC4411156)

Galiè, N. et al. (2015) Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. New England Journal of Medicine, 373(9), pp. 834-844. (doi:10.1056/NEJMoa1413687) (PMID:26308684)

Locke, A. E. et al. (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), pp. 197-206. (doi:10.1038/nature14177) (PMID:25673413) (PMCID:PMC4382211)

Loeffen, R., Winckers, K., Ford, I., Jukema, J. W., Robertson, M., Stott, D. J., Spronk, H. M., ten Cate, H., and Lowe, G. (2015) Associations between thrombin generation and the risk of cardiovascular disease in elderly patients: results from the PROSPER study. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 70(8), pp. 982-988. (doi:10.1093/gerona/glu228) (PMID:25540034)

Logue, J. et al. (2015) SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in Scotland. BMJ Open, 5(5), e008106. (doi:10.1136/bmjopen-2015-008106) (PMID:26002692) (PMCID:PMC4442215)

MacDonald, T. M. et al. (2015) Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial: figure 1. BMJ Open, 5(8), e007645. (doi:10.1136/bmjopen-2015-007645) (PMID:26253566)

Mccowan, C., Thomson, E., Szmigielski, C. A., Kalra, D., Sullivan, F. M., Prokosch, H.-U., Dugas, M., and Ford, I. (2015) Using electronic health records to support clinical trials: a report on stakeholder engagement for EHR4CR. BioMed Research International, 2015, 707891. (doi:10.1155/2015/707891) (PMID:26539523) (PMCID:PMC4619877)

Poortvliet, R. K.E. et al. (2015) Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. American Journal of Hypertension, 28(4), pp. 469-479. (doi:10.1093/ajh/hpu181) (PMID:25298176)

Templin, C. et al. (2015) Clinical features and outcomes of takotsubo (stress) cardiomyopathy. New England Journal of Medicine, 373(10), pp. 929-938. (doi:10.1056/NEJMoa1406761) (PMID:26332547)

Williams, B. et al. (2015) Prevention And treatment of hypertension with algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension. BMJ Open, 5(8), e008951. (doi:10.1136/bmjopen-2015-008951) (PMID:26253568) (PMCID:PMC4538257)

McCowan, C., and Ford, I. (2014) Clinical trials in crisis: four simple methodologic fixes commentary. Clinical Trials, 11(6), pp. 624-625. (doi:10.1177/1740774514553483)

Mccowan, C., and Ford, I. (2014) Commentary on Vickers. Clinical Trials, 11(6), pp. 624-625. (doi:10.1177/1740774514553483) (PMID:25389226)

Welsh, P. et al. (2014) Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia, 57(12), pp. 2513-2520. (doi:10.1007/s00125-014-3383-9)

Steg, P. G. et al. (2014) Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the international observational CLARIFY registry. JAMA Internal Medicine, 174(10), pp. 1651-1659. (doi:10.1001/jamainternmed.2014.3773) (PMID:25110899)

Tendera, M. et al. (2014) Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. International Journal of Cardiology, 176(1), pp. 119-124. (doi:10.1016/j.ijcard.2014.06.052) (PMID:25042656)

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., and Ferrari, R. (2014) Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure. New England Journal of Medicine, 371(12), pp. 1091-1099. (doi:10.1056/NEJMoa1406430) (PMID:25176136)

Anker, S.D. et al. (2014) The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. European Heart Journal, 35(30), pp. 2001-2009. (doi:10.1093/eurheartj/ehu205)

Wijsman, L. W. et al. (2014) N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Annals of Neurology, 76(2), pp. 213-222. (doi:10.1002/ana.24203)

Witham, M. D., Price, R. J.G., Struthers, A. D., Donnan, P. T., Messow, M., McConnachie, A., Ford, I., and McMurdo, M. E.T. (2014) Effect of vitamin D supplementation on orthostatic hypotension. Journal of Hypertension, 32(8), pp. 1693-1699. (doi:10.1097/HJH.0000000000000223) (PMID:24879494)

Akao, H. et al. (2014) ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment. Atherosclerosis, 235(1), pp. 176-181. (doi:10.1016/j.atherosclerosis.2014.04.030) (PMID:24854628)

Komajda, M., Böhm, M., Borer, J. S., Ford, I., Robertson, M., Manolis, A. J., Tavazzi, L., and Swedberg, K. (2014) Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT. European Journal of Heart Failure, 16(7), pp. 810-816. (doi:10.1002/ejhf.114)

Postmus, I. et al. (2014) In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. Atherosclerosis, 235(1), pp. 58-64. (doi:10.1016/j.atherosclerosis.2014.04.009)

Carrick, D. et al. (2014) A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). Journal of the American College of Cardiology, 63(20), pp. 2088-2098. (doi:10.1016/j.jacc.2014.02.530)

Cooke, J. A. et al. (2014) Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. Health Technology Assessment, 18(28), v-vi, 1. (doi:10.3310/hta18280)

Lubitz, S.A. et al. (2014) Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. Journal of the American College of Cardiology, 63(12), pp. 1200-1210. (doi:10.1016/j.jacc.2013.12.015)

Voors, A. A., van Veldhuisen, D. J., Robertson, M., Ford, I., Borer, J. S., Bohm, M., Komajda, M., Swedberg, K., and Tavazzi, L. (2014) The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT. European Journal of Heart Failure, 16(4), pp. 426-434. (doi:10.1002/ejhf.59)

Di Angelantonio, E. et al. (2014) Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA: Journal of the American Medical Association, 311(12), pp. 1225-1233. (doi:10.1001/jama.2014.1873) (PMID:24668104) (PMCID:PMC4386007)

Virgini, V.S. et al. (2014) Subclinical thyroid dysfunction and functional capacity among elderly. Thyroid, 24(2), pp. 208-214. (doi:10.1089/thy.2013.0071)

Borer, J.S., Böhm, M., Ford, I., Robertson, M., Komajda, M., Tavazzi, L., and Swedberg, K. (2014) Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT Study). American Journal of Cardiology, 113(3), pp. 497-503. (doi:10.1016/j.amjcard.2013.10.033)

Preiss, D., Lloyd, S. M., Ford, I., McMurray, J. J.V., Holman, R. R., Welsh, P., Fisher, M., Packard, C. J., and Sattar, N. (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes and Endocrinology, 2(2), pp. 116-124. (doi:10.1016/S2213-8587(13)70152-9) (PMID:24622715)

Drewes, Y.M. et al. (2014) Homocysteine levels and treatment effect in the prospective study of pravastatin in the elderly at risk. Journal of the American Geriatrics Society, 62(2), pp. 213-221. (doi:10.1111/jgs.12660)

Jennings, C., Flynn, R., Ford, I., Nuki, G., MacDonald, T., and Mackenzie, I. (2014) Up-titration of allopurinol in patients with gout. Scottish Medical Journal, 59(1), E24-E25. (doi:10.1177/0036933013518461)

Avery, C.L. et al. (2014) Drug–gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval. Pharmacogenomics Journal, 14(1), pp. 6-13. (doi:10.1038/tpj.2013.4)

Baumert, J. et al. (2014) No evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: results from meta-analyses of 80,607 subjects. PLoS ONE, 9(12), e111156. (doi:10.1371/journal.pone.0111156)

Bots, M.L., Ford, I., Lloyd, S.M., Laurent, S., Touboul, P.J., and Hennerici, M.G. (2014) Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial. Stroke, 45(8), pp. 2348-2353. (doi:10.1161/STROKEAHA.114.004775)

Deelen, J. et al. (2014) Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Human Molecular Genetics, 23(16), pp. 4420-4432. (doi:10.1093/hmg/ddu139)

Ferrari, R., Ford, I., Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H., Fox, K., Hu, D., Shalnova, S., and Steg, P. G. (2014) Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. European Journal of Preventive Cardiology, 22(8), pp. 1056-1065. (doi:10.1177/2047487314547652)

Holmes, M. V. et al. (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ, 349, g4164. (doi:10.1136/bmj.g4164)

Huang, J. et al. (2014) Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arteriosclerosis, Thrombosis and Vascular Biology, 34(5), pp. 1093-1101. (doi:10.1161/ATVBAHA.113.302088)

Kalra, P. R. et al. (2014) Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS ONE, 9(7), e102335. (doi:10.1371/journal.pone.0102335)

Lewsey, J.D. et al. (2014) A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation. Heart, 101(3), pp. 201-208. (doi:10.1136/heartjnl-2014-305637)

Lundby, A. et al. (2014) Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics. Nature Methods, 11(8), pp. 868-874. (doi:10.1038/NMETH.2997)

MacDonald, T. M. et al. (2014) Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open, 4(7), e005354. (doi:10.1136/bmjopen-2014-005354)

McConnachie, A., Walker, A., Robertson, M., Marchbank, L., Peacock, J., Packard, C.J., Cobbe, S.M., and Ford, I. (2014) Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. European Heart Journal, 35(5), pp. 290-298. (doi:10.1093/eurheartj/eht232)

Oei, L. et al. (2014) A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus. Journal of Medical Genetics, 51(2), pp. 122-131. (doi:10.1136/jmedgenet-2013-102064)

Postmus, I. et al. (2014) Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nature Communications, 5(5068), (doi:10.1038/ncomms6068)

Sinner, M. F. et al. (2014) Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation, 130(15), pp. 1225-1235. (doi:10.1161/CIRCULATIONAHA.114.009892)

Taylor, A. E. et al. (2014) Stratification by smoking status reveals an association of CHRNA5-A3-B4 genotype with body mass index in never smokers. PLoS Genetics, 10(12), e1004799. (doi:10.1371/journal.pgen.1004799)

Wood, A. R. et al. (2014) Defining the role of common variation in the genomic and biological architecture of adult human height. Nature Genetics, 46(11), pp. 1173-1186. (doi:10.1038/ng.3097)

Tavazzi, L., Swedberg, K., Komajda, M., Böhm, M., Borer, J.S., Lainscak, M., Robertson, M., and Ford, I. (2013) Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. International Journal of Cardiology, 170(2), pp. 182-188. (doi:10.1016/j.ijcard.2013.10.068)

Cavanagh, J. et al. (2013) Socioeconomic status and the cerebellar grey matter volume. Data from a well-characterised population sample. Cerebellum, 12(6), pp. 882-891. (doi:10.1007/s12311-013-0497-4)

Parsa, A. et al. (2013) Common variants in mendelian kidney disease genes and their association with renal function. Journal of the American Society of Nephrology, 24(12), pp. 2105-2117. (doi:10.1681/ASN.2012100983)

Sabayan, B., van der Grond, J., Westendorp, R.G., Jukema, J.W., Ford, I., Buckley, B.M., Sattar, N., van Osch, M.J.P., van Buchem, M.A., and de Craen, A.J.M. (2013) Total cerebral blood flow and mortality in old age: a 12-year follow-up study. Neurology, 81(22), pp. 1922-1929. (doi:10.1212/01.wnl.0000436618.48402.da)

Holmes, M.V. et al. (2013) Secretory phospholipase A2-IIA and cardiovascular disease. Journal of the American College of Cardiology, 62(21), pp. 1966-1976. (doi:10.1016/j.jacc.2013.06.044)

Reil, J., Tardif, J., Ford, I., Lloyd, S.M., O'Meara, E., Komajda, M., Borer, J.S., Tavazzi, L., Swedberg, K., and Böhm, M. (2013) Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. Journal of the American College of Cardiology, 62(21), pp. 1977-1985. (doi:10.1016/j.jacc.2013.07.027)

Witham, M. D., Price, R. J.G., Struthers, A. D., Donnan, P. T., Messow, C.-M., Ford, I., and McMurdo, M. E.T. (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension the VitDISH randomized controlled trial. JAMA Internal Medicine, 173(18), pp. 1672-1679. (doi:10.1001/jamainternmed.2013.9043)

Ruschitzka, F. et al. (2013) Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex. New England Journal of Medicine, 369(15), pp. 1395-1405. (doi:10.1056/NEJMoa1306687)

Fox, K., Bousser, M., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Hennerici, M.G., Mattle, H.P., and Rothwell, P.M. (2013) Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history of ischemic stroke or transient ischemic attack) study population. International Journal of Cardiology, 168(4), pp. 3500-3505. (doi:10.1016/j.ijcard.2013.04.206)

Berry, C. et al. (2013) Fractional flow reserve versus angiography in guiding management to optimize outcomes in non–ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial. American Heart Journal, 166(4), 662-668.e3. (doi:10.1016/j.ahj.2013.07.011)

Fox, K., Ford, I., Steg, P.G., Tardif, J., Tendera, M., and Ferrari, R. (2013) Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure. American Heart Journal, 166(4), 654-661.e6. (doi:10.1016/j.ahj.2013.06.024) (PMID:24093844)

Inglis, S.C. et al. (2013) Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. International Journal of Cardiology, 168(2), pp. 1094-1101. (doi:10.1016/j.ijcard.2012.11.033)

Barry, S. J. E., Dinnett, E., Kean, S., Gaw, A., and Ford, I. (2013) Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland coronary prevention study. PLoS ONE, 8(9), e75379. (doi:10.1371/journal.pone.0075379) (PMID:24058681) (PMCID:PMC3772901)

Ferrari, R., Abergel, H., Ford, I., Fox, K.M., Greenlaw, N., Steg, P.G., Hu, D., Tendera, M., and Tardif, J. (2013) Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. International Journal of Cardiology, 167(6), pp. 2938-2943. (doi:10.1016/j.ijcard.2012.08.013) (PMID:22985742)

Krishnadas, R. et al. (2013) Socioeconomic deprivation and cortical morphology: psychological, social, and biological determinants of ill health study. Psychosomatic Medicine, 75(7), pp. 616-623. (doi:10.1097/PSY.0b013e3182a151a7)

Scott, R.A. et al. (2013) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nature Genetics, 44(9), pp. 991-1005. (doi:10.1038/ng.2385)

Carrick, D. et al. (2013) A randomised controlled trial of deferred stenting versus immediate stenting to prevent no-reflow in acute ST-elevation myocardial infarction. Scottish Medical Journal, 58(3), e41-e41. (doi:10.1177/0036933013495794)

Mooijaart, S.P., Sattar, N., Trompet, S., Lucke, J., Stott, D.J., Ford, I., Jukema, J.W., Westendorp, R.G.J., and de Craen, A.J.M. (2013) Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. Journal of Internal Medicine, 274(1), pp. 77-85. (doi:10.1111/joim.12052)

Smith, B. H. et al. (2013) Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. International Journal of Epidemiology, 42(3), pp. 689-700. (doi:10.1093/ije/dys084)

Berry, C., Lloyd, S.M., Wang, Y., MacDonald, A., and Ford, I. (2013) The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. European Heart Journal, 34(21), pp. 1538-1547. (doi:10.1093/eurheartj/ehs339)

Nanchen, D. et al. (2013) Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study. European Journal of Heart Failure, 15(5), pp. 581-588. (doi:10.1093/eurjhf/hfs195)

Postmus, I., Trompet, S., de Craen, A.J.M., Buckley, B.M., Ford, I., Stott, D.J., Sattar, N., Slagboom, P.E., Westendorp, R.G.J., and Jukema, J.W. (2013) PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population. Journal of Lipid Research, 54(2), pp. 561-566. (doi:10.1194/jlr.P033969)

Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J.R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., and Tavazzi, L. (2013) Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clinical Research in Cardiology, 102(1), pp. 11-22. (doi:10.1007/s00392-012-0467-8)

Komajda, M., Bohm, M., Borer, J., Ford, I., Krum, H., Tase, A., Tavazzi, L., and Swedberg, K. (2013) Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure. European Journal of Heart Failure, 15(1), pp. 79-84. (doi:10.1093/eurjhf/hfs127)

Abrahamsson, P., Swedberg, K., Borer, J.S., Bohm, M., Kober, L., Komajda, M., Lloyd, S.M., Metra, M., Tavazzi, L., and Ford, I. (2013) Risk following hospitalization in stable chronic systolic heart failure. European Journal of Heart Failure, 15(8), pp. 885-891. (doi:10.1093/eurjhf/hft032)

Filippatos, G. et al. (2013) Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. European Journal of Heart Failure, 15(11), pp. 1267-1276. (doi:10.1093/eurjhf/hft099)

Fox, K. et al. (2013) Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. European Heart Journal, 34(29), pp. 2263-2270. (doi:10.1093/eurheartj/eht101)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15(11), pp. 1253-1261. (doi:10.1093/eurjhf/hft085)

Jackson, C.E. et al. (2013) Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply. European Journal of Heart Failure, 14(6), pp. 676-677. (doi:10.1093/eurjhf/hfs050)

Krishnadas, R. et al. (2013) Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: results from the psychological, social and biological determinants of ill health (pSoBid) study. NeuroImage: Clinical, 2(2013), pp. 646-657. (doi:10.1016/j.nicl.2013.04.012)

Lloyd, S.M. et al. (2013) Long-term effects of statin treatment in elderly people: Extended follow-up of the PROspective study of Pravastatin in the elderly at risk (PROSPER). PLoS ONE, 8(9), e72642. (doi:10.1371/journal.pone.0072642)

MacDonald, T.M., Mackenzie, I.S., Wei, L., Hawkey, C.J., and Ford, I. (2013) Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). BMJ Open, 2013(3), e002295. (doi:10.1136/bmjopen-2012-002295)

McCarthy, M.I. et al. (2013) A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genetics, 9(2), e1003266. (doi:10.1371/journal.pgen.1003266)

Millar, K. et al. (2013) Personality, socio-economic status and inflammation: cross-sectional, population-based study. PLoS ONE, 8(3), e58256. (doi:10.1371/journal.pone.0058256)

Reil, J.-C., Robertson, M., Ford, I., Borer, J., Komajda, M., Swedberg, K., Tavazzi, L., and Bohm, M. (2013) Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure. European Journal of Heart Failure, 15(9), pp. 1044-1052. (doi:10.1093/eurjhf/hft072)

Sabayan, B. et al. (2013) Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study. BMJ Open, 347, f4600. (doi:10.1136/bmj.f4600)

Singh, A. et al. (2013) Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations. BMJ Open, 3(12), e004348-e004348. (doi:10.1136/bmjopen-2013-004348)

Stock, S.J., Ferguson, E., Duffy, A., Ford, I., Chalmers, J., and Norman, J.E. (2013) Outcomes of induction of labour in women with previous caesarean delivery: a retrospective cohort study using a population database. PLoS ONE, 8(4), e60404. (doi:10.1371/journal.pone.0060404)

Stuart, W.P., Hussey, K.K., Eifell, R.K.G., Drummond, R., Ford, I., and Welch, G.H. (2013) Using centrally held data to validate carotid surgery outcome data. Stroke, 44(6), pp. 1670-1675. (doi:10.1161/STROKEAHA.111.000200)

Tavazzi, L., Swedberg, K., Komajda, M., Bohm, M., Borer, J.S., Lainscak, M., and Ford, I. (2013) Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study. European Journal of Heart Failure, 15(11), pp. 1296-1303. (doi:10.1093/eurjhf/hft102)

Verschuren, J.J.W. et al. (2013) Non-homologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data. PLoS ONE, 8(2), e56262. (doi:10.1371/journal.pone.0056262)

Welsh, P., Doolin, O., Willeit, P., Packard, C., Macfarlane, P., Cobbe, S., Gudnason, V., Di Angelantonio, E., Ford, I., and Sattar, N. (2013) N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. European Heart Journal, 34(6), pp. 443-450. (doi:10.1093/eurheartj/ehs239)

Witham, M.D., Price, R.J.G., Struthers, A.D., Donnan, P.T., Messow, C., Ford, I., and McMurdo, M.T. (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension. JAMA Internal Medicine, 173(18), pp. 1672-1679. (doi:10.1001/jamainternmed.2013.9043)

McLean, J. et al. (2012) Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations. Behavioural Brain Research, 235(2), pp. 225-230. (doi:10.1016/j.bbr.2012.08.013)

Borer, J.S., Bohm, M., Ford, I., Komajda, M., Tavazzi, L., Sendon, J.L., Alings, M., Lopez-de-Sa, E., and Swedberg, K. (2012) Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. European Heart Journal, 33(22), pp. 2813-2820. (doi:10.1093/eurheartj/ehs259)

Steg, P.G., Greenlaw, N., Tardif, J.-C., Tendera, M., Ford, I., Kaab, S., Abergel, H., Fox, K.M., and Ferrari, R. (2012) Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. European Heart Journal, 33(22), pp. 2831-2840. (doi:10.1093/eurheartj/ehs289)

Miller, A. M. et al. (2012) Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? PLoS ONE, 7(10), e47830. (doi:10.1371/journal.pone.0047830) (PMID:23112853) (PMCID:PMC3480428)

Kaptoge, S. et al. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine, 367(14), pp. 1310-1320. (doi:10.1056/NEJMoa1107477)

Mihaylova, B. et al. (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet, 380(9841), pp. 581-590. (doi:10.1016/S0140-6736(12)60367-5)

Payne, A. R. et al. (2012) Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. Journal of the American Heart Association, 1(4), e002246. (doi:10.1161/JAHA.112.002246)

Hocking, L.J. et al. (2012) Heritability of chronic pain in 2195 extended families. European Journal of Pain, 16(7), pp. 1053-1063. (doi:10.1002/j.1532-2149.2011.00095.x)

Knox, S. et al. (2012) 25-hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis, 223(2), pp. 437-441. (doi:10.1016/j.atherosclerosis.2012.05.001) (PMID:22632919)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308(8), pp. 804-811. (doi:10.1001/jama.2012.8439)

Di Angelantonio, E. et al. (2012) Lipid-related markers and cardiovascular disease prediction. JAMA: Journal of the American Medical Association, 307(23), pp. 2499-2506. (doi:10.1001/jama.2012.6571)

Deshmukh, H.A. et al. (2012) Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a). Journal of Lipid Research, 53(5), pp. 1000-1011. (doi:10.1194/jlr.P021113)

Deshmukh, H.A. et al. (2012) Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importnace of Lp(a). Journal of Lipid Research, 53, pp. 1000-1011. (doi:10.1194/jlr.P021113)

Estrada, K. et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature Genetics, 44(5), pp. 491-501. (doi:10.1038/ng.2249)

Swedberg, K., Komajda, M., Bohm, M., Borer, J., Robertson, M., Tavazzi, L., and Ford, I. (2012) Effects on outcomes of heart rate reduction by Ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose? Findings from the SHIFT (Systolic Heart Failure Treatment with I-f inhibitor ivabradine Trial) Study. Journal of the American College of Cardiology, 59(22), pp. 1938-1945. (doi:10.1016/j.jacc.2012.01.020)

Swerdlow, D.I. et al. (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet, 379(9822), pp. 1214-1224. (doi:10.1016/S0140-6736(12)60110-X)

Nanchen, D. et al. (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 97(3), pp. 852-861. (doi:10.1210/jc.2011-1978)

McGuinness, D. et al. (2012) Socio-economic status is associated with epigenetic differences in the pSoBid cohort. International Journal of Epidemiology, 41(1), pp. 151-160. (doi:10.1093/ije/dyr215)

Rapsomaniki, E., White, I.R., Wood, A.M., Thompson, S.G., and Ford, I. (2012) A framework for quantifying net benefits of alternative prognostic models. Statistics in Medicine, 31(2), pp. 114-130. (doi:10.1002/sim.4362)

Akao, H. et al. (2012) Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly. Atherosclerosis, 220(2), pp. 413-417. (doi:10.1016/j.atherosclerosis.2011.09.028)

Akao, H. et al. (2012) KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly. Atherosclerosis, 220(2), pp. 456-462. (doi:10.1016/j.atherosclerosis.2011.11.037)

Charchar, F.J. et al. (2012) Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet, 379(9819), pp. 915-922. (doi:10.1016/S0140-6736(11)61453-0)

Chasman, D.I. et al. (2012) Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Human Molecular Genetics, 21(24), pp. 5329-5343. (doi:10.1093/hmg/dds369)

Emberson, J.R. et al. (2012) Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS ONE, 7(1), e29849. (doi:10.1371/journal.pone.0029849)

Gibson, G. et al. (2012) Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genetics, 8(3), e1002584. (doi:10.1371/journal.pgen.1002584)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans (MTWA) testing in 'real world' heart failure (HF): a study of prevalence and incremental prognostic value. Heart, 2012(98), A12. (doi:10.1136/heartjnl-2012-301877b.17)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14(6), p. 678. (doi:10.1093/eurjhf/hfs077)

Jackson, C.E. et al. (2012) Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. European Journal of Heart Failure, 14(4), pp. 377-386. (doi:10.1093/eurjhf/hfs010)

Manning, A.K. et al. (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nature Genetics, 44, pp. 659-669. (doi:10.1038/ng.2274)

Poortvliet, R.K.E. et al. (2012) Blood pressure variability and cardiovascular risk in the PROspective study of pravastatin in the elderly at risk (PROSPER). PLoS ONE, 7(12), e52438. (doi:10.1371/journal.pone.0052438)

Shiffman, D. et al. (2012) Genome-wide study of gene variants associated with differential cardiovascular event reduction by Pravastatin therapy. PLoS ONE, 7(5), e38240. (doi:10.1371/journal.pone.0038240)

Steg, P.G., Ferrari, R., Ford, I., Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H., and Fox, K. (2012) Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS ONE, 7(5), e36284. (doi:10.1371/journal.pone.0036284)

Stock, S.J., Ferguson, E., Duffy, A., Ford, I., Chalmers, J., and Norman, J.E. (2012) Outcomes of elective induction of labour compared with expectant management: population based study. British Medical Journal, 344, e2838. (doi:10.1136/bmj.e2838)

Trompet, S., Jukema, W., Mooijaart, S.P., Ford, I., Stott, D.J., Westendorp, R.G.J., and de Craen, A.J.M. (2012) Genetic variation in galectin-3 gene associates with cognitive function at old age. Neurobiology of Aging, 33(9), 2232.e1-2232.e9. (doi:10.1016/j.neurobiolaging.2012.05.001)

Wormser, D. et al. (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. International Journal of Epidemiology, 41(5), pp. 1419-1433. (doi:10.1093/ije/dys086)

Ford, I. et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology, 40(6), pp. 1530-1538. (doi:10.1093/ije/dyr172)

Berry, C., Lloyd, S.M., Wang, Y., MacDonald, A., and Ford, I. (2011) The changing course of aortic valve disease in Scotland: hospitalizations, outcomes and temporal trends. Circulation, 124(21S), A16931.

van Es, A.C.G.M. et al. (2011) Cerebral microbleeds and cognitive functioning in the PROSPER study. Neurology, 77(15), pp. 1446-1452. (doi:10.1212/WNL.0b013e318232ab1d)

Trompet, S. et al. (2011) Replication of LDL SWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses. BMC Medical Genetics, 12, p. 131. (doi:10.1186/1471-2350-12-131)

Welsh, P. et al. (2011) Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arteriosclerosis, Thrombosis and Vascular Biology, 31(10), pp. 2338-2344. (doi:10.1161/ATVBAHA.111.231795) (PMID:21757655)

Ekman, I., Chassany, O., Komajda, M., Bohm, M., Borer, J.S., Ford, I., Tavazzi, L., and Swedberg, K. (2011) Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. European Heart Journal, 32(19), pp. 2395-2404. (doi:10.1093/eurheartj/ehr343)

Mooijaart, S.P. et al. (2011) C-Reactive protein and genetic variants and cognitive decline in old age: the PROSPER Study. PLoS ONE, 6(9), e23890. (doi:10.1371/journal.pone.0023890)

Trew, G. et al. (2011) Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction, 26(8), pp. 2015-2027. (doi:10.1093/humrep/der135)

Bousser, M.G. et al. (2011) Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet, 377(9782), pp. 2013-2022. (doi:10.1016/S0140-6736(11)60600-4)

Widya, R. L. et al. (2011) Increased amygdalar and hippocampal volumes in elderly obese individuals with or at risk of cardiovascular disease. American Journal of Clinical Nutrition, 93(6), pp. 1190-1195. (doi:10.3945/ajcn.110.006304)

Logue, J., Murray, H.M., Welsh, P., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2011) Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart, 97(7), pp. 564-568. (doi:10.1136/hrt.2010.211201)

Rahimi, K. et al. (2011) Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. British Medical Journal, 342, d1250. (doi:10.1136/bmj.d1250)

Tendera, M., Talajic, M., Robertson, M., Tardif, J.-C., Ferrari, R., Ford, I., Steg, P.G., and Fox, K. (2011) Safety of Ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy). American Journal of Cardiology, 107(6), pp. 805-811. (doi:10.1016/j.amjcard.2010.10.065)

Wensley, F. et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ, 342, d548-d548. (doi:10.1136/bmj.d548)

Ceconi, C. et al. (2011) Effect of heart rate reduction by ivabradine on left ventricular remodelling in the echocardiographic substudy of BEAUTIFUL. International Journal of Cardiology, 146(3), pp. 408-414. (doi:10.1016/j.ijcard.2010.10.125)

Wade, A.G., Crawford, G., Ford, I., McConnachie, A., Nir, T., Laudon, M., and Zisapel, N. (2011) Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Current Medical Research and Opinion, 27(1), pp. 87-98. (doi:10.1185/03007995.2010.537317)

Freeman, D. et al. (2011) Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatrics, 11(8), (doi:10.1186/1471-2318-11-8)

Li, Y. et al. (2011) Genetic variants in the KIF6 region and coronary event reduction from statin therapy. Human Genetics, 129(1), pp. 17-23. (doi:10.1007/s00439-010-0892-6)

Macfarlane, P.W., Murray, H., Sattar, N., Stott, D.J., Ford, I., Buckley, B., Jukema, J.W., Westendorp, R.G.J., and Shepherd, J. (2011) The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace, 13(5), pp. 634-639. (doi:10.1093/europace/eur016)

Mutsaerts, H.J.M.M. et al. (2011) Diastolic carotid artery wall shear stress is associated with cerebral infarcts and periventricular white matter lesions. Stroke, 42(12), pp. 3497-3501. (doi:10.1161/STROKEAHA.111.614453)

Packard, C.J. et al. (2011) Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health, 11, p. 42. (doi:10.1186/1471-2458-11-42)

Payne, A.R., Berry, C., Doolin, O., McEntegart, M.B., Robb, S.D., Petrie, M.C., Ford, I., and Oldroyd, K. (2011) Myocardial salvage during primary PCI can be predicted in the cath lab. Heart, 97(Sup. 1), A73-A74. (doi:10.1136/heartjnl-2011-300198.129)

Pons, D. et al. (2011) Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies. Heart, 97(2), pp. 143-150. (doi:10.1136/hrt.2010.199927)

Reil, J.C., Custodis, F., Swedberg, K., Komajda, M., Borer, J.S., Ford, I., Tavazzi, L., Laufs, U., and Bohm, M. (2011) Heart rate reduction in cardiovascular disease and therapy. Clinical Research in Cardiology, 100(1), pp. 11-19. (doi:10.1007/s00392-010-0207-x)

Shiels, P.G. et al. (2011) Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS ONE, 6(7), e22521. (doi:10.1371/journal.pone.0022521)

Smith, N. L. et al. (2011) Genetic predictors of fibrin D-Dimer levels in healthy adults. Circulation, 123(17), pp. 1864-1872. (doi:10.1161/CIRCULATIONAHA.110.009480)

Tardif, J.-C., O'Meara, E., Komajda, M., Bohm, M., Borer, J. S., Ford, I., Tavazzi, L., and Swedberg, K. (2011) Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. European Heart Journal, 32(20), pp. 2507-2515. (doi:10.1093/eurheartj/ehr311)

Van Veldhuisen, D.J. et al. (2011) Intrathroacic impedance monitoring, audible patient alerts and outcome in patients with heart failure. Circulation, 124(16), pp. 1719-1726.

van Veldhuisen, D.J. et al. (2011) Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation, 124(16), pp. 1719-1726. (doi:10.1161/CIRCULATIONAHA.111.043042)

Bohm, M., Swedberg, K., Komajda, M., Borer, J.S., Ford, I., Dubost-Brama, A., Lerebours, G., and Tavazzi, L. (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet, 376(9744), pp. 886-894. (doi:10.1016/S0140-6736(10)61259-7)

Swedkerg, K., Komajda, M., Bohm, M., Borer, J.S., Ford, I., Dubost-Brama, A., Lerebours, G., and Tavazzi, L. (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 376(9744), pp. 875-885. (doi:10.1016/S0140-6736(10)61198-1)

Iakoubova, O.A. et al. (2010) KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study. European Journal of Cardiovascular Prevention and Rehabilitation, 17(4), pp. 455-461. (doi:10.1097/HJR.0b013e328336a0dd)

Ford, I., Robertson, M., Shepherd, J., and Cobbe, S. (2010) Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet, 375(9726), pp. 1634-1639. (doi:10.1016/S0140-6736(10)60545-4)

Caslake, M.J. et al. (2010) Lipoprotein-associated phospholipase A2 inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Atherosclerosis, 210(1), pp. 28-34. (doi:10.1016/j.atherosclerosis.2009.10.041)

Polisecki, E. et al. (2010) Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly. Journal of Lipid Research, 51(5), pp. 1201-1207. (doi:10.1194/jlr.P001172)

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375(9716), pp. 735-742. (doi:10.1016/S0140-6736(09)61965-6)

Parthasarathy, H. K., Alhashmi, K., McMahon, A. D., Struthers, A. D., McInnes, G. T., Ford, I., Connell, J. M., and MacDonald, T. M. (2010) Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO. Journal of Hypertension, 28(1), pp. 170-177. (doi:10.1097/HJH.0b013e328332b79b)

Matthan, N.R., Resteghini, N., Robertson, M., Ford, I., Shepherd, J., Packard, C., Buckley, B.M., Jukema, J.W., Lichenstein, A.H., and Schaefer, E.J. (2010) Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial. Journal of Lipid Research, 51, pp. 202-209. (doi:10.1194/jlr.M900032-JLR200)

Swedberg, K., Komajda, M., Böhm, M., Borer, J.S., Ford, I., and Tavazzi, L. (2010) Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT). European Journal of Heart Failure, 12(1), pp. 75-81. (doi:10.1093/eurjhf/hfp154)

Trompet, S. et al. (2010) Pravastatin and cognitive function in the elderly. Results of the PROSPER study. Journal of Neurology, 257(1), pp. 85-90. (doi:10.1007/s00415-009-5271-7)

Welsh, P. et al. (2010) Unraveling the directional link between adiposity and inflammation: a bidirectional mendelian randomization approach. Journal of Clinical Endocrinology and Metabolism, 95(1), pp. 93-99. (doi:10.1210/jc.2009-1064)

Elliot, H.L., Lloyd, S.M., Ford, I., and Meredith, P.A. (2010) Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk. International Journal of Hypertension, 2010(Articl), (doi:10.4061/2010/490769)

Hennerici, M.G., Bots, M.L., Ford, I., Laurent, S., and Touboul, P.J. (2010) Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history oF ischemic stroke or transient ischemic attack (PERFORM) trial. Cardiovascular Drugs and Therapy, 24(2), pp. 175-180. (doi:10.1007/s10557-010-6231-2)

Preiss, D., Welsh, P., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up(dagger). European Heart Journal, 31(10), pp. 1230-1236. (doi:10.1093/eurheartj/ehq095)

Ray, K. K., Seshasai, S. R. K., Erqou, S., Sever, P., Jukema, J. W., Ford, I., and Sattar, N. (2010) Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants. Archives of Internal Medicine, 170(12), pp. 1024-1031. (doi:10.1001/archinternmed.2010.182)

Sofat, R. et al. (2010) Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation, 121(1), pp. 52-62. (doi:10.1161/CIRCULATIONAHA.109.865444)

Stott, D.J. et al. (2010) Activation of Hemostasis and Decline in Cognitive Function in Older People. Arteriosclerosis, Thrombosis and Vascular Biology, 30(3), pp. 605-611. (doi:10.1161/ATVBAHA.109.199448)

Wade, A.G., Ford, I., Crawford, G., McConnachie, A., Nir, T., Laudon, M., and Zisapel, N. (2010) Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Medicine, 8, p. 51. (doi:10.1186/1741-7015-8-51)

Trompet, S. et al. (2009) Apolipoprotein E genotype, plasma cholesterol, and cancer: a mendelian randomization study. American Journal of Epidemiology, 170(11), pp. 1415-1421. (doi:10.1093/aje/kwp294)

Batty, G.D., Wang, Y., Brouilette, S.W., Shiels, P.G., Packard, C.J., Moore, J., Samani, N.J., and Ford, I. (2009) Socioeconomic status and telomere length: the West of Scotland Coronary Prevention Study. Journal of Epidemiology and Community Health, 63(10), pp. 839-841. (doi:10.1136/jech.2009.088427)

Fox, K., Ford, I., Steg, G., Tendera, M., Robertson, M., and Ferrari, R. (2009) Relationship between Ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. European Heart Journal, 30(19), pp. 2337-2345. (doi:10.1093/eurheartj/ehp358)

Bousser, M.G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M., Mattle, H.P., and Rothwell, P.M. (2009) The prevention of cerebrovascular and cardiovascular events of ischemic origin with Terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study: Baseline characteristics of the population. Cerebrovascular Diseases, 27(6), p. 608. (doi:10.1159/000216835)

Davidson, K.M. et al. (2009) Cognitive behaviour therapy for violent men with antisocial personality disorder in the community: an exploratory randomized controlled trial. Psychological Medicine, 39(4), pp. 569-577. (doi:10.1017/S0033291708004066)

Bousser, M.G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M.G., Mattle, H.P., and Rothwell, P.M. (2009) Rationale and design of a randomized, double-blind, parallel-group study of Terutroban 30 mg/day versus Aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular Diseases, 27(5), p. 509. (doi:10.1159/000212671)

Shepherd, J., Lowe, G., Ford, I., and Robertson, M. (2009) Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Statistics in Medicine, 28(7), pp. 1067-1092. (doi:10.1002/sim.3530)

Stott, D.J., Welsh, P.I., Rumley, A., Robertson, M., Ford, I., Sattar, N.A., Westendorp, R.G.J., Jukema, J.W., Cobbe, S., and Lowe, G.D. (2009) Adipocytokines and risk of stroke in older people: a nested case-control study. International Journal of Epidemiology, 38(1), pp. 253-261. (doi:10.1093/ije/dyn215)

Welsh, P. et al. (2009) Leptin Predicts Diabetes but Not Cardiovascular Disease Results from a large prospective study in an elderly population. Diabetes Care, 32(2), pp. 308-310. (doi:10.2337/dc08-1458)

Deans, K.A. et al. (2009) Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study. British Medical Journal, 339, b4170. (doi:10.1136/bmj.b4170)

Ford, I. et al. (2009) Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Medicine, 6(1), e1000016. (doi:10.1371/journal.pmed.1000016)

Jackson, C.E., Dalzell, J.R., Bezlyak, V., Tsorlalis, I.K., Myles, R.C., Spooner, R., Ford, I., Petrie, M.C., Cobbe, S., and McMurray, J.J. (2009) Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. European Journal of Heart Failure, 11(12), pp. 1152-1154. (doi:10.1093/eurjhf/hfp157)

Sattar, N.A. et al. (2009) Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Medicine, 6(6), e1000099. (doi:10.1371/journal.pmed.1000099)

Sattar, N. et al. (2009) Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia, 52(2), pp. 235-239.

Trompet, S., de Craen, A.J.M., Mooijaart, S., Stott, D.J., Ford, I., Sattar, N.A., Jukema, W., and Westendorp, R.G.J. (2009) High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER study. Clinical Cancer Research, 15(24), pp. 7744-7748. (doi:10.1158/1078-0432.CCR-09-2152)

Watkins, S. et al. (2009) Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation, 120(22), pp. 2207-2213. (doi:10.1161/CIRCULATIONAHA.109.872358)

Weir, R.A.P., Mark, P.B., Petrie, C.J., Clements, S., Steedman, T., Ford, I., Ng, L.L., Squire, I.B., Wagner, G.S., and McMurray, J.J.V. (2009) Left ventricular remodeling after acute myocardial infarction: Does eplerenone have an effect? American Heart Journal, 157(6), pp. 1088-1096. (doi:10.1016/j.ahj.2009.04.001)

Fox, K., Ford, I., Steg, P.G., Tendera, M., and Ferrari, R. (2008) Ivabradine in heart failure: what about digoxin? Lancet, 372(9656), pp. 2113-2114. (doi:10.1016/S0140-6736(08)61924-8)

Fox, K., Ford, I., Steg, P.G., Tendera, M., and Ferrari, R. (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet, 372(9641), pp. 807-816. (doi:10.1016/S0140-6736(08)61170-8)

Fox, K., Ford, I., Steg, P.G., Tendera, M., Robertson, M., and Ferrari, R. (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet, 372(9641), pp. 817-821. (doi:10.1016/S0140-6736(08)61171-X)

Braunschweig, F. et al. (2008) Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). European Journal of Heart Failure, 10(9), pp. 907-916. (doi:10.1016/j.ejheart.2008.06.016)

Polisecki, E. et al. (2008) Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response and cardiovascular disease incidence in PROSPER. Atherosclerosis, 200(1), pp. 109-114.

Ferrari, R., Ford, I., Fox, K., Steg, P.G., and Tendera, M. (2008) The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction – baseline characteristics of the study population. Cardiology, 110(4), pp. 271-282. (doi:10.1159/000112412)

Sattar, N. et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet, 371(9628), pp. 1927-1935. (doi:10.1016/S0140-6736(08)60602-9)

Ford, I., Murray, H., and Cobbe, S. (2008) Long-term follow-up of the West of Scotland Coronary Prevention Study - Reply. New England Journal of Medicine, 358(2), pp. 194-195.

Downs, J.R. et al. (2008) Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet, 371(9607), pp. 117-125. (doi:10.1016/S0140-6736(08)60104-X)

Parthasarathy, H., Alhashmi, K., Struthers, A., Connell, J., McInnes, G., Ford, I., and MacDonald, T. (2008) Does the aldosterone: Renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension: The Renaldo study. Heart, 94, A19-A19.

Poliseckia, E. et al. (2008) Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population. Atherosclerosis, 200(1), pp. 95-101. (doi:10.1016/j.atherosclerosis.2007.12.005)

Stott, D., Falconer, A., Kerr, G., Murray, H., Trompet, S., Westendorp, R., Buckley, B., De Craen, A., Sattar, N., and Ford, I. (2008) Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People? Journal of the American Geriatrics Society, 56(12), pp. 2217-2224. (doi:10.1111/j.1532-5415.2008.02007.x)

Trompet, S. et al. (2008) Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study. Experimental Gerontology, 43(8), pp. 801-805. (doi:10.1016/j.exger.2008.04.006)

Trompet, S. et al. (2008) Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain, 131(4), pp. 1069-1077. (doi:10.1093/brain/awn023)

Velupillai, Y.N. et al. (2008) Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study. BMC Public Health, 8(126), (doi:10.1186/1471-2458-8-126)

Wild, S., Macleod, F., McKnight, J., Watt, G., Mackenzie, C., Ford, I., McConnachie, A., and Lindsay, R. (2008) Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study. Diabetic Medicine, 25(2), pp. 194-199. (doi:10.1111/j.1464-5491.2008.02382.x)

Packard, C.J. et al. (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults. Journal of the American Geriatrics Society, 55(11), pp. 1777-1785. (doi:10.1111/j.1532-5415.2007.01415.x)

Sattar, N., McConnachie, A., Ford, I., Gaw, A., Cleland, S.J., Forouhi, N.G., Macfarlane, P., Shepherd, J., Cobbe, S., and Packard, C. (2007) Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study - Specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes, 56(4), pp. 984-991. (doi:10.2337/db06-1256)

Brouilette, S., Moore, J., McMahon, D., Thompson, J., Ford, I., Shepherd, J., Packard, C., and Samani, N. (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet, 369, pp. 107-114.

Brown, D., Kauermann, G., and Ford, I. (2007) A partial likelihood approach to smooth estimation of dynamic covariate effects using penalised splines. Biometrical Journal, 49, pp. 441-452. (doi:10.1002/bimj.200510325)

Capell, H. et al. (2007) Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Annals of the Rheumatic Diseases, 66, pp. 235-241. (doi:10.1136/ard.2006.057133) (PMID:16926184)

Ford, I., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., and Cobbe, S. (2007) Long-term follow-up of the West of Scotland Coronary Prevention Study. New England Journal of Medicine, 357(15), pp. 1477-1486. (doi:10.1056/NEJMoa065994)

Parthasarathy, H.K., Alhashmi, K., McMahon, A., Struthers, A.D., Connell, J.M.C., McInnes, G.T., Ford, I., and MacDonald, T.M. (2007) Does the aldosterone : renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study. BMC Cardiovascular Disorders, 7(14), (doi:10.1186/1471-2261-7-14)

Ruzyllo, W., Tendera, M., Ford, I., and Fox, K. (2007) Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris - A 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs, 67, pp. 393-405.

Sattar, N. et al. (2007) C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER). Circulation, 115(8), pp. 981-989. (doi:10.1161/CIRCULATIONAHA.106.643114)

Wade, A., Ford, I., Crawford, G., McMahon, A., Nir, T., Laudon, M., and Zisapel, N. (2007) Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of age sleep and next-day alertness outcomes. Current Medical Research and Opinion, 23, pp. 2597-2605. (doi:10.1185/030079907X233098)

Osman, I., Mackenzie, F., Norrie, J., Murray, H., Greer, I.A., Norman, J.E., and Ford, I. (2006) The 'PRIM' study: a randomized comparison of prostaglandin E2 gel with the nitric donor isosorbide mononitrate for cervical ripening before the induction of labour at term. American Journal of Obstetrics and Gynecology, 194(4), pp. 1012-1021. (doi:10.1016/j.ajog.2005.10.812)

Al Benna, S., Hamilton, C.A., McClure, J.D., Rogers, P.N., Berg, G.A., Ford, I., Delles, C., and Dominiczak, A.F. (2006) Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Arteriosclerosis, Thrombosis and Vascular Biology, 26(1), pp. 218-223. (doi:10.1161/01.ATV.0000193626.22269.45)

Fox, K., Ferrari, R., Tendera, M., Steg, P., Ford, I., and BEAUTIFUL Steering Committee, (2006) Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I-f inhibitor ivabradine in pat. American Heart Journal, 152, pp. 860-866. (doi:10.1016/j.ahj.2006.01.013)

Smith, B.H. et al. (2006) Generation Scotland: the Scottish family health study; a new resource for researching genes and heritability. BMC Medical Genetics, 7, p. 74. (doi:10.1186/1471-2350-7-74)

Walker, A., McMurray, J., Stewart, S., Berger, W., McMahon, A., Dargie, H., Fox, K., Hillis, S., Henderson, N., and Ford, I. (2006) Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart, 92, pp. 619-624. (doi:10.1136/hrt.2003.026385)

Will, M., Bernacca, G., Bell, E., Tolland, M., Lowe, G., Rumley, A., Murray, H., Ford, I., and Wheatley, D. (2006) Our inability to predict thromboembolic events after prosthetic valve surgery. Journal of Heart Valve Disease, 15(4), pp. 570-580.

Tardif, J.-C., Ford, I., Tendera, M., Bourassa, M.G., and Fox, K. (2005) Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. European Heart Journal, 26(23), pp. 2529-2536. (doi:10.1093/eurheartj/ehi586)

Brady, A.J.B., Norrie, J., and Ford, I. (2005) Statin prescribing: is the reality meeting the expectations of primary care? British Journal of Cardiology, 12(5), pp. 397-400.

ten Dam, V.H., van den Heuvel, D.M.J., van Buchem, M.A., Westendorp, R.G.J., Bollen, E.L.E.M., Ford, I., de Craen, A.J.M., and Blauw, G.J. (2005) Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology, 64(10), pp. 1807-1809. (doi:10.1212/01.WNL.0000161844.00797.73)

Brzezinski, A., Vangel, M., Wurtman, R., Norrie, G., Zhdanova, I., Ben-Shushan, A., and Ford, I. (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9, pp. 41-50. (doi:10.1016/j.smrv.2004.06.004)

Dargie, H. et al. (2005) Determinants of coronary events in patients with stable angina: Results from the Impact of Nicorandil in Angina Study. American Heart Journal, 150, (doi:10.1016/j.ahj.2005.03.040)

Kamper, A., Stott, D., Hyland, M., Murray, H., and Ford, I. (2005) Predictors of functional decline in elderly people with vascular risk factors or disease. Age and Ageing, 34, pp. 450-455. (doi:10.1093/ageing/afi137)

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, D., and Ford, I. (2005) Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. Journal of the American College of Cardiology, 45, pp. 525-530.

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, N., and Ford, I. (2005) Antiarrythmic effect of carvedilol after acute myocardial infarction. Journal of the American College of Cardiology, 45(4), pp. 525-530. (doi:10.1016/j.jacc.2004.09.076)

Packard, C.J. et al. (2005) Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation, 112, pp. 3058-3065. (doi:10.1161/CIRCULATIONAHA.105.526848)

Tardif, J., Ford, I., Tendera, M., Bourassa, M., Fox, K., and Initiative Investigators, (2005) Efficacy of ivabradine, a new selective I-f inhibitor, compared with atenolol in patients with chronic stable angina. European Heart Journal, 26, pp. 2529-2536. (doi:10.1093/eurheartj/ehi586)

Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKillop, J.H., and Packard, C.J. (2004) Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. Atherosclerosis Supplements, 5(3), pp. 91-97. (doi:10.1016/j.atherosclerosissup.2004.08.029)

McCarey, D.W., McInnes, I.B., Madhok, R., Hampson, R., Scherbakov, O., Ford, I., Capell, H., and Sattar, N. (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet, 363(9426), pp. 2015-2021. (doi:10.1016/S0140-6736(04)16449-0) (PMID:15207950)

Cleland, J., Findlay, I., Jafri, S., Sutton, G., Falk, R., Bulpitt, C., Prentice, C., Ford, I., Trainer, A., and Poole-Wilson, P. (2004) The Warfarin/Aspirin Study in Heart failure (WASH): A randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal, 148, pp. 157-164. (doi:10.1016/j.ahj.2004.03.010)

Dargie, H. et al. (2004) Impact of nicorandil in angina: subgroup analyses. Heart, 90, pp. 1427-1430. (doi:10.1136/hrt.2003.026310)

Ford, I., Lowe, G.D.O., McMahon, A.D., O'Reilly, D.S., Packard, C.J., and Rumley, A. (2004) Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arteriosclerosis, Thrombosis and Vascular Biology, 24, pp. 1529-1534. (doi:10.1161/01.ATV.0000135995.39488.6c)

Kostis, J.B. et al. (2004) Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 11(1), pp. 9-17.

Lees, K.R. et al. (2004) Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet, 363, pp. 439-445.

Sattar, N., Scherbakova, O., Ford, I., O'Reilly, D., Stanley, A., Forrest, E., MacFarlane, P., Packard, C., Cobbe, S., and Shepherd, J. (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes, 53(11), pp. 2855-2860. (doi:10.2337/diabetes.53.11.2855)

Sattar, N. et al. (2004) Metabolic syndrome and diabetes mellitus - Response. Circulation, 109(3), E23-E23.

O'Dwyer, P.J. et al. (2003) Local or general anesthesia for open hernia repair: a randomized trial. Annals of Surgery, 237(4), pp. 574-579.

Daly, C., Norrie, J., Murdoch, D., Ford, I., Dargie, H., and Fox, K. (2003) The value of routine non-invasive tests to predict clinical outcome in stable angina. European Heart Journal, 24, pp. 534-542. (doi:10.1016/S0195-668X(02)00820-5)

Pell, J., Sirel, J., Marsden, A., Ford, I., Walker, N., and Cobbe, S. (2003) Presentation, management, and outcome of out of hospital cardiopulmonary arrest: comparison by underlying aetiology. Heart, 89(8), pp. 839-842. (doi:10.1136/heart.89.8.839)

Pell, J., Sirel, J., Walker, N., Cobbe, S., Marsden, A., and Ford, I. (2003) Public access defibrillators - Defibrillators in public places save lives - Reply. British Medical Journal, 326(7381), p. 163.

Sattar, N. et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108(4), pp. 414-419. (doi:10.1161/01.CIR.0000080897.52664.94)

Avorn, J. et al. (2002) Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Controlled Clinical Trials, 23, pp. 757-773.

Dargie, H., Ford, I., Fox, K., and Hillis, W. (2002) Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet, 359, pp. 1269-1275.

Ford, I. et al. (2002) A prospective study of pravastatin in the elderly at risk (PROSPER): Screening experience and baseline characteristics. Current Controlled Trials in Cardiovascular Medicine, 3, p. 8. (doi:10.1186/1468-6708-3-8)

Ford, I., and Norrie, J. (2002) The role of covariates in estimating treatment effects and risk in long-term clinical trials. Statistics in Medicine, 21, pp. 2899-2908. (doi:10.1002/sim.1294)

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D. S. J.,, Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600. (doi:10.2337/diabetes.51.5.1596)

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D.S., Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600.

Houx, P.J. et al. (2002) Testing cognitive function in elderly populations: the PROSPER study. Journal of Neurology, Neurosurgery and Psychiatry, 73(4), pp. 385-389. (doi:10.1136/jnnp.73.4.385)

Kostis, J. et al. (2002) Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. American Journal of Hypertension, 15(2), pp. 193-198. (doi:S0895-7061(01)02048-9)

Otterstad, J., and Ford, I. (2002) The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction - How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-bl. European Journal of Heart Failure, 4, pp. 501-506.

Shepherd, J. et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 360(9346), pp. 1623-1630. (doi:10.1016/S0140-6736(02)11600-X)

Simes, J., Furberg, C., Braunwald, E., Davis, B., Ford, I., Tonkin, A., and Shepherd, J. (2002) Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels - The Prospective Pravastatin Pooling project. European Heart Journal, 23, pp. 207-215. (doi:10.1053/euhj.2001.2775)

Streja, L., Packard, C., Shepherd, J., Cobbe, S., and Ford, I. (2002) Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS). American Journal of Cardiology, 90(7), pp. 731-736. (doi:10.1016/S0002-9149(02)02599-7)

Blue, L. et al. (2001) Randomised controlled trial of specialist nurse intervention in heart failure. British Medical Journal, 323, pp. 715-718. (doi:10.1136/bmj.323.7315.715)

Freeman, D. et al. (2001) Pravastatin and the development of diabetes mellitus - Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 103(3), pp. 357-362.

McDonagh, T., Cunningham, A., Morrison, C., McMurray, J., Ford, I., Morton, J., and Dargie, H. (2001) Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart, 86, pp. 21-26.

Pell, J.P., Sirel, J.M., Marsden, A.K., Ford, I., and Cobbe, S.M. (2001) Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. British Medical Journal, 322, pp. 1385-1388. (doi:10.1136/bmj.322.7299.1385)

Packard, C.J. et al. (2000) Lipoprotein-associated phospholipse A2 as an independent predictor of coronary heart disease (WOSCOPS). New England Journal of Medicine, 343(16), pp. 1148-1155. (doi:10.1056/NEJM200010193431603)

L'Itallien, G., Ford, I., Norrie, J., LaPuerta, P., Ehreth, J., Jackson, J., and Shepherd, J. (2000) The cardiovascular event reduction tool(CERT)- a simplified cardiac risk prediction model developed fron the West of Scotland coronary prevention study (WOSCOPS). American Journal of Cardiology, 85(6), pp. 720-724. (doi:10.1016/S0002-9149(99)00847-4)

Gaw, A., Brown, E.A., Docherty, G., and Ford, I. (2000) Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? a nested case control study from the West of Scotland coronary prevention study. Atherosclerosis, 148(1), pp. 95-100. (doi:10.1016/S0021-9150(99)00259-2)

Lowe, G., Rumley, A., Norrie, J., Ford, I., Shepherd, J., Cobbe, S., Macfarlane, P., and Packard, C. (2000) Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thrombosis and Haemostasis, 84(4), pp. 553-558.

Packard, C.J. et al. (2000) Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease. New England Journal of Medicine, 343(16), pp. 1148-1155.

Pell, J., Pell, A.C.H., Norrie, J., Ford, I., and Cobb, S.M. (2000) Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. British Medical Journal, 320, pp. 15-18. (doi:10.1136/bmj.320.7226.15)

Gaw, A., Brown, E.D., Docherty, G., and Ford, I. (1999) Use of the West of Scotland coronary prevention study bio-bank to provide new insights into the control of plasma lipoprotein(a) concentrations. Biochemical Society Transactions, 27(4), pp. 459-463.

Gaw, A., Docherty, G., Brown, E., and Ford, I. (1999) Predictors of plasma lipoprotein(a) concentration in the West of Scotland coronary prevention study cohort. Atherosclerosis, 143(2), pp. 445-450. (doi:10.1016/S0021-9150(98)00305-0)

Cleland, J.G.F. et al. (1999) The WASH study (warfarin/aspirin study in heart failure) rationale, design and end-points. European Journal of Heart Failure, 1(1), pp. 95-99.

Packard, C., Shepherd, J., Cobbe, S., Ford, I., Isles, C.G., McKillop, J.H., MacFarlane, P.W., Lorimer, A.R., and Norrie, J. (1998) Influence of pravastatin and plasma lipids on clinical events in the West of Scotland coronary prevention study (WOSCOPS). Circulation, 97(15), pp. 1440-1445.

McDonagh, T., Robb, S.D., Murdoch, D.R., Morton, J.J., Ford, I., Morrison, C.E., Tunstall-Pedoe, H., McMurray, J., and Dargie, H. (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet, 351(9095), pp. 9-13. (doi:10.1016/S0140-6736(97)03034-1)

Gaw, A., Brown, E., and Ford, I. (1998) Impact of Aapo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect. Arteriosclerosis, Thrombosis and Vascular Biology, 18, pp. 1870-1876. (doi:10.1161/01.ATV.18.12.1870)

Caro, J., Klittoch, W., McGuire, A., Ford, I., Norrie, J., Pettitt, D., McMurray, J., and Shepherd, J. (1997) The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. British Medical Journal, 315, pp. 1577-1582. (doi:10.1136/bmj.315.7122.1577)

McDonagh, T.A., Morrison, C.E., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J.J.V., and Dargie, H.J. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet, 350(9081), pp. 829-833. (doi:10.1016/S0140-6736(97)03033-X)

Patel, D.J., Mulcahy, D., Norrie, J., Wright, C., Clarke, D., Ford, I., and Fox, K.M. (1996) Natural variability of transient myocardial ischaemia during daily life: an obstacle when assessing efficacy of anti-ischaemic agents? Heart, 76, pp. 477-482.

Cobbe, S.M., Dalziel, K., Ford, I., and Marsden, A.K. (1996) Survival of 1476 patients initally resuscitated from out-of-hospital cardiac-arrest. British Medical Journal, 312, pp. 1633-1637. (doi:10.1136/bmj.312.7047.1633)

Fox, K.M., Mulcahy, D., Findlay, I., Ford, I., and Dargie, H. (1996) The Total Ischaemic Burden European Trial (TIBET): effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. European Heart Journal, 17(1), pp. 96-103.

Fox, K.M., Mulcahy, D., Findlay, I., Ford, I., and Dargie, H. (1996) Total Ischaemic Burden European Trial (TIBET): effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. European Heart Journal, 17(1), pp. 104-112.

Holmes, A.P., Blair, R.C., Watson, J.D., and Ford, I. (1996) Nonparametric analysis of statistic images from functional mapping experiments. Journal of Cerebral Blood Flow and Metabolism, 16, pp. 7-22. (doi:10.1097/00004647-199601000-00002)

Patel, D.J., Mulcahy, D., Norrie, J., Sparrow, J., Wright, C., Ford, I., and Fox, K.M. (1995) Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy? European Heart Journal, 16(12), pp. 1773-1779.

Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., Macfarlane, P.W., McKillop, J.H., and Packard, C.J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine, 333(20), pp. 1301-1308. (doi:10.1056/NEJM199511163332001)

Ford, I. (1995) Some nonontological and functionally unconnected views on current issues in the analysis of PET datasets. Journal of Cerebral Blood Flow and Metabolism, 15(3), pp. 371-377. (doi:10.1038/jcbfm.1995.46)

Ford, I., Norrie, J., and Ahmadi, S. (1995) Model inconsistency, illustrated by Cox proportional hazards model. Statistics in Medicine, 14(8), pp. 735-746. (doi:10.1002/sim.4780140804)

Martin, B.J., Devine, B.L., MacDonald, J.B., Williams, J., Kiggins, P., Norrie, J., and Ford, I. (1995) Incidence of pressure sores in geriatric long-term hospital care. Journal of Tissue Viability, 5, pp. 83-88.

Metcalfe, M., and Ford, I. (1995) Contribution of perindopril in the treatment of congestive heart failure. Drugs of Today, 31, pp. 39-44.

McColl, J.H., Holmes, A.P., and Ford, I. (1994) Statistical methods in neuroimaging with particular application to emission tomography. Statistical Methods in Medical Research, 3(1), pp. 63-86.

Ray, S.G., Pye, M., Oldroyd, K.G., Christie, J., Connelly, D., Norhtridge, D., Morton, J.J., Ford, I., Dargie, H., and Cobbe, S. (1993) Early treatment with Captopril after acute myocardial infarction. British Heart Journal, 69(3), pp. 215-222.

Dargie, H., Fox, K.M., and Ford, I. (1993) Clinical trials in silent ischaemia: lessons from TIBET. Archives de Maladies du Coeur et des Vaisseaux, 86, pp. 31-34.

Graham, D.I., Adams, J.H., Doyle, D., Ford, I., Gennarelli, T.A., Lawrence, A.E., Maxwell, W.L., and McLean, D.R. (1993) Quantification of primary and secondary lesions in severe head injury. Acta Neurochirurgica: Supplementum, 57, pp. 41-48.

Ford, I., Torsney, B., and Wu, C.F.J. (1992) The use of a canonical form in the construction of locally optimal designs for non-linear problems. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 54(2), pp. 569-583.

McCrory, S.J., and Ford, I. (1991) Multivariate analysis of SPECT images with illustrations in Alzheimer's disease. Statistics in Medicine, 10(11), pp. 1711-1718.

Oldroyd, K.G., Pye, M.P., Ray, S.G., Christie, J., Ford, I., Cobbe, S.M., and Dargie, H.J. (1991) Effects of early Captopril administration on infarct expansion, left ventricular remodelling and exercise capacity after acute myocardial infarction. American Journal of Cardiology, 68(8), pp. 713-718. (doi:10.1016/0002-9149(91)90641-W)

Ford, I., McColl, J.H., McCormack, A.G., and McCrory, S.J. (1991) Statistical issues in the analysis of neuroimages. Journal of Cerebral Blood Flow and Metabolism, 11(2), A89-A95.

McLenachan, J.M., Grant, S., Ford, I., Henderson, E., and Dargie, H.J. (1991) Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during tredmill excerise: a study of Celiprolol and Atenolol. American Heart Journal, 121(2), pp. 691-696.

Ford, I. (1991) Angina clinical trial methodology. Postgraduate Medical Journal, 67(Sup 3), S2-S8.

Kerr, W.J.S., and Ford, I. (1991) The variability of some craniofacial dimensions. Angle Orthodontist, 61(3), pp. 205-210.

Kotapka, M.J., Gennarelli, T.A., Graham, D.I., Adams, J.H., Thibault, L.E., Ross, D.T., and Ford, I. (1991) Selective vulnerability of hippocampal neurons in acceleration-induced experimental head injury. Journal of Neurotrauma, 8(4), pp. 247-258.

Pickard, M.A., Venner, R.M., Ford, I., and Todd, B.D. (1990) The influence of immediate physiotherapy in the out-patient management of acute knee injuries: a controlled study. Archives of Emergency Medicine, 7(4), pp. 249-252.

Northbridge, D.B., Grant, S., Ford, I., Christie, J., McLenachan, J., Connelly, D., McMurray, J., Ray, S., Henderson, E., and Dargie, H.J. (1990) Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer. British Heart Journal, 64(5), pp. 313-316.

Hirst, D.J., Ford, I., and Critchley, F. (1990) An empirical investigation of methods for interval estimation of the log odds ratio in discriminant analysis. Biometrika, 77(3), pp. 609-615.

Adams, J.H., Doyle, D., Ford, I., Gennarelli, T.A., Graham, D.I., and McLellan, D.R. (1989) Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology, 15(1), pp. 49-59. (doi:10.1111/j.1365-2559.1989.tb03040.x)

Adams, J.H., Doyle, D., Ford, I., Graham, D.I., McGee, M., and McLellan, D.R. (1989) Brain damage in fatal non-missile head injury in relation to age and type of injury. Scottish Medical Journal, 34(1), pp. 399-401.

Graham, D.I., Ford, I., Adams, J.H., Doyle, D., Lawerence, A.E., and McLellan, D.R. (1989) Fatal head injury in children. Journal of Clinical Pathology, 42(1), pp. 18-22.

Graham, D.I., Ford, I., Adams, J.H., Doyle, D., Teasdale, F.M., Lawrence, A.E., and McLellan, D.R. (1989) Ischaemic brain damage is still common in fatal non-missile head injury. Journal of Neurology, Neurosurgery and Psychiatry, 52(3), pp. 346-350. (doi:10.1136/jnnp.52.3.346)

McColl, J.H., Ford, I., McGhee, M.A., Brooks, D.N., and Murphy, J.B. (1989) Referal patterns of elderly patients with dementia or depression. Health Bulletin, 47(6), pp. 273-281.

Ng, T., Graham, D.I., Adams, J.H., and Ford, I. (1989) Changes in the hippocampus and the cerebellum resulting from hypoxic insults: frequency & distribution. Acta Neuropathologica, 78(4), pp. 438-443. (doi:10.1007/BF00688181)

Critchley, F., Ford, I., and Rijal, O. (1988) Interval estimation based on the profile likelihood: strong Lagrangrain theory, with applications to discrimination. Biometrika, 75(1), pp. 21-28.

Dargie, H.J., Cleland, J.G.F., Leckie, B.J., Inglis, G.G., East, B.W., and Ford, I. (1987) The relation of arythmmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation, 75(5), pp. 98-107.

Osbourne, K.A., Shigeno, T., Balarsky, A.M., Ford, I., McCulloch, J., Teasdale, G.M., and Graham, D.I. (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. Journal of Neurology, Neurosurgery and Psychiatry, 50(4), pp. 402-410.

Cleland, J.G., Dargie, H.J., and Ford, I. (1987) Mortality in heart failure: clinical variables of prognostic value. British Heart Journal, 58(6), pp. 572-582.

Wrona, F.J., Calow, P., Ford, I., Baird, D.J., and Maltby, L. (1986) Estimating the abundance of stone dwelling organisms: A new method. Canadian Journal of Fisheries and Aquatic Sciences, 43(10), pp. 2025-2035. (doi:10.1139/f86-248)

Kelly, P.A.T., Ford, I., and McCulloch, J. (1986) The effect of diazepam upon local cerebral glucose use in the conscious rat. Neuroscience, 19(1), pp. 257-265. (doi:10.1016/0306-4522(86)90019-9)

Ford, I. (1986) Confunded correlations: statistical limitations in the analysis of interregional relationships of cerebral metabolic activity. Journal of Cerebral Blood Flow and Metabolism, 6(3), pp. 385-388.

Kerr, W.J.S., and Ford, I. (1986) A comparison of facial form in three Western European male groups. European Journal of Orthodontics, 8(2), pp. 106-111.

Cleland, J.G.F., Dargie, H., McAlpine, H., Ball, S.G., Morton, J.J., Robertson, J.I.S., and Ford, I. (1985) Severe hypotension after 1st dose of Enalapril in heart failure. British Medical Journal, 291(6505), pp. 1309-1312.

Cleland, J.G.F., Dargie, H., Ball, S.G., Gillen, G., Hodsman, G.P., Morton, J.J., East, B.W., Robertson, I., Ford, I., and Robertson, J.I.S. (1985) Effects of Enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones and metabolic state. Heart, 54(3), pp. 305-312.

Critchley, F., and Ford, I. (1985) Interval estimation in discrimination: the multivariate normal equal covariance case. Biometrika, 72(1), pp. 109-116. (doi:10.2307/2336340)

Ford, I., Titterington, D., and Wu, C.F.J. (1985) Inference and sequential design. Biometrika, 72(3), pp. 545-551. (doi:10.2307/2336726)

Critchley, F., and Ford, I. (1984) On the covariance of 2 noncentral F-random variable and the variance of the estimated linear discriminant function. Biometrika, 71(3), pp. 637-368. (doi:10.2307/2336578)

Cleland, J., Semple, P., Ball, S., Ford, I., Dargie, H., and Hodsman, P. (1984) Angiotensin II levels, hemodynamics and sympathoadrenal function after low-dose Captopril in heart failure. American Journal of Medicine, 77(5), pp. 880-886. (doi:10.1016/0002-9343(84)90530-8)

Smith, N., Soutter, W.P., Sharp, F., McColl, J., and Ford, I. (1983) Fetal scalp blood lactate as an indicator of intrapartum hypoxia. British Journal of Obstetrics and Gynaecology, 90(9), pp. 821-831. (doi:10.1111/j.1471-0528.1983.tb09322.x)

McCulloch, J., Kelly, P.A.T., and Ford, I. (1982) Effect of Apomorphine on the relationship between local cerebral glucose-utilization and local cerebral blood-flow (with an appendix on its statistical-analysis). Journal of Cerebral Blood Flow and Metabolism, 2(4), pp. 487-499. (doi:10.1038/jcbfm.1982.56)

Ford, I., and Silvey, S.D. (1980) A sequentially constructed design for estimating a nonlinear parametric function. Biometrika, 67(2), pp. 381-388. (doi:10.1093/biomet/67.2.381)

Book Sections

Trompet, S. et al. (2007) Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events - The PROSPER study. In: Rattan, S. and Akman, S. (eds.) Biogerontology: Mechanisms and Interventions. Series: Annals of the New York Academy of Sciences (1100). Blackwell Publishing: Oxford, pp. 189-198. ISBN 978-1-57331-679-8 (doi:10.1196/annals.1395.018)

Ford, I., and Holmes, A.P. (1998) Functional neuroimaging and statistics. In: Everitt, B.S. and Dunn, G. (eds.) In Statistical Analysis of Medical Data: New Developments. Oxford University Press: London, UK, pp. 277-305. ISBN 9780340677759

This list was generated on Fri May 27 07:22:59 2016 BST.